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ABSTRACT 
Background: Abdominal aortic aneurysm (AAA) is defined as a dilatation of the abdominal 
aorta of 30 mm in diameter or more. Main risk factors are smoking, age and male sex. 
Pathophysiological features include inflammation, smooth muscle cell loss and destruction 
of the extracellular matrix. The AAA is typically asymptomatic but can expand and 
eventually rupture, with a mortality of 70-80% as a result. Risk factors for rupture include a 
large diameter, female sex, active smoking, high blood pressure and low body mass index 
(BMI). There is no medical treatment to inhibit growth or rupture of AAA. The only measure 
to prevent rupture in a large AAA is aortic surgery. This intervention carries its own 
significant risk of morbidity and mortality, necessitating a risk stratification method. The 
diameter is currently used to decide when to operate on an AAA and it is repeatedly 
monitored until the threshold for surgery is reached. However, this measurement leaves room 
for improvement, as the individual aneurysm growth rate is difficult to predict and some large 
AAAs do not rupture while in other patients, small AAAs rupture during surveillance. Finite 
element analysis (FEA) is a method by which biomechanical rupture risk can be estimated 
based on patient characteristics and a computed tomography (CT)-derived 3D model of an 
AAA. Microarray analysis allows high-throughput analyses of tissue gene expression. 
Aims: The overall aim of this thesis was to explore and develop new strategies to improve, 
refine and individualize management of patients with AAA, by applying geometric, 
biomechanical and molecular analyses. 
Methods and Results:  In study I, the CTs of 146 patients with AAAs of diameters between 
40 and 60 mm were analyzed with three-dimensional (3D) segmentation and FEA. Simple 
and multiple regression analyses were performed. Female sex, patient height, lumen volume, 
body surface area (BSA) and low BMI were shown to be associated with the biomechanical 
rupture risk of AAA. Study II included 191 patients with AAAs of diameters between 40-50 
mm. The AAAs were analyzed with 3D segmentation and FEA after which prediction 
algorithms were developed by use of machine learning strategies. More precise diameter 
measurements improved prediction of growth and four-year prognosis of small AAAs. 
Biomechanical indices and lumen diameter were predictive of future rupture or symptomatic 
AAA. Growth and rupture required different prediction models. In study III, 37 patients, 42 
controls and a validation cohort of 51 patients were analyzed with respect to their circulating 
levels of neutrophil elastase-derived fibrin degradation products (E-XDP). The results 
showed that E-XDP was a sensitive marker for AAA, independently of examined 
comorbidities, and its concentration in peripheral blood correlated with the AAA diameter 
and the volume and mechanical stress of the intraluminal thrombus (ILT). It was further 
increased by the presence of coexisting aneurysms. Study IV included 246 tissue samples, 
divided into tunica media and adventitia, from 76 patients with AAA and 13 organ donor 
controls, analyzed by microarrays. There were large differences between the transcriptomes 
of AAA and control media and adventitia. Processes related to inflammation were transmural, 
whereas the upregulation of proteolysis, angiogenesis and apoptosis along with 
downregulation of smooth muscle- and differentiation-related gene sets were specific for the 
aneurysm media. Active smoking increased oxidative stress in all tissues and increased 
inflammation and lipid-related processes in AAA. The growth rate of the AAA diameter 
correlated with adaptive immunity in media and lipid processes in adventitia. 
Conclusions: In this thesis, we show that known clinical risk factors and certain geometric 
properties are associated with biomechanical deterioration of AAAs. Furthermore, geometric 
and biomechanical analyses can enhance prediction of outcome. Importantly, there are 
differences between prediction of AAA growth and rupture. Finally, a biomarker was 
discovered and the transcriptome of AAA including effects of the ILT, smoking and rapid 
diameter growth rate, was mapped and we envision that the data may be used for future 
biomarker and drug target discovery.   
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POPULÄRVETENSKAPLIG SAMMANFATTNING 
Introduktion: Pulsåderbråck på buksegmentet av den stora kroppspulsådern kallas 
bukaortaaneurysm (BAA) och drabbar ca 1,5% av alla 65-åriga män och 0,5% av alla 70-
åriga kvinnor i Sverige. Riskfaktorer för att utveckla BAA är bland andra rökning, manligt 
kön och hög ålder. Sjukdomen innebär att kroppspulsådern utvidgas i diameter på grund av 
nedbrytning av den normalt stabiliserande vävnaden i kärlväggen. I vanliga fall ger inte BAA 
några symptom. Med ökande diameter ökar dock risken för bristning, ett tillstånd med svår 
rygg-buksmärta och inre blödning. Ett brustet BAA orsakar en dödlighet på 70-80%. 
Riskfaktorer för bristning hos patienter med BAA är kvinnligt kön, rökning, högt blodtryck 
och lågt kroppsmasseindex (BMI). Det enda sättet att förhindra tillväxt och bristning av ett 
BAA är operation, det finns ingen medicinsk behandling. Operation av BAA är dock ett 
omfattande ingrepp med risk för död och komplikationer. Därför opereras inte alla patienter 
med BAA. Kirurgi övervägs när diametern är 55 mm hos män och 52 mm hos kvinnor. 
Mindre BAA övervakas regelbundet med ultraljud och/eller skiktröntgen tills de uppnår 
denna operationsindikation. Diametern är inte en perfekt indikator på risk för bristning. Det 
är svårt att förutsäga hur snabbt ett specifikt BAA kommer att tillväxa samt när, och om, det 
kommer att bli föremål för kirurgi. De senaste decennierna har datoriserade 
hållfasthetsberäkningar, baserade på 3D-modeller, utvecklats för att uppskatta biomekanisk 
belastning i ett BAA och det har också blivit möjligt att mäta uttrycket av alla gener i en 
vävnad samtidigt, med så kallad microarray-teknik.   
Målsättningar: Den övergripande målsättningen var att utveckla nya geometriska, 
biomekaniska och molekylärbiologiska metoder som kan förbättra och individanpassa 
handläggningen av patienter med BAA.  
Metod och Resultat: I den första studien inkluderades 146 patienter och 
hållfasthetsberäkningar av BAA utfördes baserade på skiktröntgenbilder. Ett starkt samband 
kunde observeras mellan kvinnligt kön, kroppslängd, rökning, lågt BMI och ökad 
biomekanisk belastning i BAA. I den andra studien inkluderades 191 patienter och analyser 
av geometri samt hållfasthet användes för att förutsäga prognos. Ökad precision i 
diametermätningar med hjälp av 3D-modellering förbättrade förutsägelser om vilka patienter 
som behövde operation inom fyra år samt hur snabbt diametern skulle tillväxa. 
Hållfasthetsberäkningar, men inte maximal diameter, kunde förutsäga vilka patienter som i 
framtiden skulle riskera att drabbas av bristning av BAA. I den tredje studien inkluderades 
37+51 patienter och 42 kontroller och nivåerna av en nedbrytningsprodukt av den kroniska 
väggfasta tromb som bildas på insidan av de flesta BAA (kallad E-XDP) uppmättes. Studien 
visade att mätning av E-XDP i blod kunde avslöja om en person har BAA eller inte och att 
dess koncentration korrelerar med BAA-diametern och trombens storlek. Den sista och fjärde 
studien inkluderade 246 vävnadsprover från 76 patienter och 13 kontroller och uttrycket av 
alla gener i dessa prover jämfördes. Resultaten kunde avslöja tusentals gener som var 
annorlunda uttryckta i BAA jämfört med kontroller. När dessa gener analyserades 
tillsammans framträdde ett flertal processer som exempelvis inflammation, nedbrytning av 
stödjevävnad samt förlust av muskelceller i kärlväggen i BAA. Några av dessa processer 
påverkades också vid rökning, samt var högt uttryckta vid snabb diametertillväxt. 
Slutsatser: Kliniska riskfaktorer för bristning är associerade med biomekanisk belastning av 
BAA och geometrisk-biomekanisk analys ökar precisionen i prognostiseringen av denna 
sjukdom. Mätning av E-XDP i blod kan avslöja BAA samt dess storlek. Det fullständiga 
genuttrycket i BAA kartlades och kan användas för framtida utveckling av blodprover och 
läkemedel. Geometriska, biomekaniska och molekylärbiologiska analyser kan användas för 
att förbättra handläggningen av patienter med AAA.
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1 INTRODUCTION 
 
1.1 OVERVIEW OF ABDOMINAL AORTIC ANEURYSM 
 
1.1.1 Definition and risk factors  
 
An arterial aneurysm is a focal and irreversible dilatation of an artery to a diameter larger than 
1.5 times the expected normal diameter (1). Aneurysms may be classified based on the affected 
arterial segment, its etiology, histopathologic features and clinical characteristics. A true 
aneurysm refers to the dilatation of the arterial vessel wall, whereas a false “pseudoaneurysm” 
refers to the contained rupture through the same. Aneurysms occur along the entire vascular 
system and etiologies range from congenital, caused by connective tissue diseases such as 
Marfan’s syndrome or Ehlers-Danlos, traumatic, inflammatory, infectious and degenerative 
(1), the latter being the exceedingly most common. Further, aneurysms may be asymptomatic 
or cause symptoms and can in the worst-case scenario lead to rupture. Abdominal aortic 
aneurysm (AAA) is an aneurysm of the abdominal aorta which preferentially affects its 
infrarenal segment (Figure 1), typically diagnosed when the diameter exceeds 30 mm (2,3). 
The most common shape of an AAA is fusiform, ie diffuse circumferential dilatation, whereas 
some aneurysms are saccular with a focal, spherical and asymmetric dilatation. Saccular 
aneurysms appear more prone to rupture at smaller diameters compared with fusiform 
aneurysms (4). The present thesis mainly concerns the common degenerative and fusiform 
AAA. Most clinically relevant AAAs contain an intraluminal thrombus (ILT), which is 
adherent to the vessel wall, very rarely cause embolic/thrombotic events and does not require 
specific treatment (5).  
Figure 1: Infrarenal abdominal aortic aneurysm. A: Aortic segments. B: infrarenal AAA imaged by 
computed tomography angiography 
Abbreviations: AAA: Abdominal aortic aneurysm 
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In contemporary Swedish studies, the screening-detected prevalence of AAA is 1.5% for men 
at age 65 (6) and 0.5% for women at age 70 (7). Nonmodifiable risk factors for AAA include 
old age, male sex and positive family history whereas African-American, Hispanic or Asian 
ethnicities appear to be protective (8,9). Smoking is the exceedingly most important modifiable 
risk factor and increases the risk of AAA in a highly dose-dependent manner. Moreover, 
individuals who quit smoking have a decreased risk of developing AAA compared with those 
who continue (8,10). Hypercholesterolemia, hypertension, cardiovascular disease and 
increased body mass index (BMI) are potentially modifiable risk factors. Another proposed 
risk factor is depression (11). Finally, diabetes mellitus, which is a strong risk factor for 
cardiovascular disease in general, appears to be negatively associated with AAA (8). 
Importantly, however, epidemiologically derived risk factors are associated but not necessarily 
causally related to the disease in question. 
 
1.1.2 Rupture 
 
The feared and often lethal complication of AAA is rupture, where a structural failure of the 
aneurysm wall occurs and a massive retro- and/or intraperitoneal hemorrhage follows. The 
patient who survives long enough to be admitted to a hospital classically presents with 
hypotension, abdominal and/or back pain and a pulsatile abdominal mass. These symptoms 
are not present in all patients and initial misdiagnosis, with for example myocardial infarction 
or ureteric colic, is common. (12). Rupture will occur in around 20% of patients with AAA 
that are denied preventive surgery, competing with other causes of death (13). The total 
mortality for patients with ruptured AAA is around 81% in women and 67% of men (14). If 
left untreated, the mortality of aortic rupture is 100% and more than half of the affected 
patients succumb before reaching hospital (15). For patients admitted to hospital, mortality 
remains high at 30-40% (16,17). Factors associated with mortality in patients operated for 
rupture include preoperative hemodynamic instability, cardiac arrest, impaired renal 
function, reduced consciousness, congestive heart failure, female sex and significant anemia 
as well as post-operative multi-organ, renal and/or respiratory failure, abdominal 
compartment syndrome and massive blood transfusion (3,14).  
  
The risk of rupture correlates with the aneurysm diameter, and this measurement is 
considered the major rupture risk indicator in current practice (18–20). Further, although 
women have a lower risk than men of developing AAA, female patients with AAA have an 
almost four times higher risk of rupture compared to male patients with an AAA of the same 
diameter (21). Other risk factors for rupture in patients with AAA include current (as opposed 
to previous) smoking, low BMI and hypertension (21). High age has been identified as a risk 
factor for rupture in a large-scale (n > 15 000) meta-analysis performed by Sweeting MJ et 
al, but in this study, full adjustment could not be performed for all potential confounders. 
However, in a smaller (n > 2000), previous study conducted by the same group, in which full 
adjustment could be made, age was not related to aneurysm rupture risk. Several risk factors, 
such as age, female sex, BMI, lung function and income, are however simultaneously related 
to operative outcome (22–26). Thus, balancing these risks clinically is challenging and a 
more patient- and aneurysm-specific rupture risk estimation would facilitate the operative 
decision. 
 
1.1.3 Diagnosis and screening 
 
AAAs may be diagnosed via targeted screening or incidentally when a computed tomography 
(CT), ultrasound (US), magnetic resonance imaging (MRI) or clinical examination of the 
abdomen is performed for other reasons. It is diagnosed by diameter measurement of the 
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abdominal aorta, where a maximal diameter of 30 mm is considered aneurysmal and 25-29 
mm could be considered sub-aneurysmal, and a quarter of the latter category will develop a 
large AAA in 15 years (2,3,27). The preferred modality to measure diameter is by US (Figure 
2A) as it is widely accessible and does not expose the patient to radiation. The measurement 
method used in Sweden is leading edge-to-leading edge (outer anterior wall to inner posterior 
wall) but ‘inner-to-inner’ and ‘outer-to-outer’ protocols are used in other countries, affecting 
the measured size of the aneurysm and thereby to some extent the prevalence of the disease 
(28). CT with intravenous contrast agent in arterial phase (CT angiography, CTA, Figure 2B) 
is the preferred modality to image in detail the anatomy of the aorta and its branches and is 
typically performed to detect any coexisting aneurysms and when the threshold for surgery 
is reached in order to plan the operation (2,3,29). With CT imaging, the recommended 
method to measure the diameter is from outer-to-outer wall perpendicularly to the estimated 
direction of the blood flow (2,3)  
 
 
Classic screening criteria apply to AAA due to the high mortality of ruptured AAA, an 
effective preventive treatment (open or endovascular surgery), an asymptomatic latent stage 
and an excellent mean of diagnosis (US) (6). Screening for AAA has been examined in four 
randomized controlled trials (RCTs) and been shown to decrease aneurysm-related and, at 
later time points, all-cause mortality (30,31). A population-wide screening program of 65-
year-old men was gradually introduced in Sweden between 2006 and 2015. Despite a 
relatively low prevalence of AAA in Sweden, an evaluation in 2016 showed that the Swedish 
screening program reduced the AAA-specific mortality and was cost-effective, with a 
numbers-needed-to-screen to prevent 1 premature death of 667 and an incremental cost-
efficiency ratio of €7770 per quality-adjusted life-year (6). Prevalence of AAA in women is 
three times lower than that in men (32). An RCT on screening for AAA in women observed 
similar, <0.2%, aneurysm-related mortality in both case and control group but the study was 
underpowered to evaluate differences at those rates (33). Female current smokers have a six 
times higher prevalence of AAA and the effect of selectively screening female smokers is 
not known. Relatives of patients with AAA have an increased risk of developing AAA 
themselves (34), and screening of individuals with a positive family history is recommended 
but has not yet been evaluated in an RCT (2,35). 
 
Figure 2:  Cross-sections of abdominal aortic aneurysms. A: Ultrasound. B: Computed tomography 
angiography.  
Abbreviations; AAA: abdominal aortic aneurysm, ILT: intraluminal thrombus. 
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Figure 2:  Cross-sections of abdominal aortic aneurysms. A: Ultrasound. B: Computed tomography 
angiography.  
Abbreviations; AAA: abdominal aortic aneurysm, ILT: intraluminal thrombus. 
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1.1.4 Non-surgical management and timing of surgery 
The only treatment to prevent the growth and rupture of an AAA is surgery (2,32,36). The 
rate of diameter growth is positively associated with smoking and negatively with diabetes 
mellitus (21). The cessation of smoking is therefore advised to slow the progression of the 
AAA towards rupture and to decrease operative risks (2,3). This could be considered the only 
available non-surgical intervention for AAA, which makes the study of the biological effects 
of smoking highly relevant. While the mortality of a AAA rupture is striking, an elective 
aortic operation is a high-risk procedure with mortality rates at around 2-3% in contemporary 
Sweden (17). This fact calls for some sort of risk stratification when surgery is considered. 
The risk of rupture increases with the diameter of the aneurysm and this measurement is used 
as indication for surgery (18–20)  
 
Four RCTs demonstrated no benefit of operating patients with an AAA < 55 mm in diameter, 
as opposed to repeated diameter measurements (‘surveillance’, see below) until the diameter 
reaches 55 mm, Table 1 (37–41). The first two of these trials, the ‘United Kingdom Small 
Aneurysm Trial’ (UKSAT) and the ‘Aneurysm Detection and Management Veterans Affairs 
Cooperative Study’ (ADAM), compared open aortic repair (OAR) to surveillance of AAAs 
of between 4 and 5.5 cm in diameter (37,38). The two following studies ‘Comparison of 
Surveillance Versus Aortic Endografting for Small Aneurysm Repair’ (CAESAR) and the 
Positive Impact of Endovascular Options for treating Aneurysms Early (PIVOTAL) instead 
studied endovascular aneurysm repair (EVAR) in small AAAs compared with surveillance 
(39,40). These studies shared similar diameter thresholds for intervention, surveillance time 
intervals and included few women. Differences include age criteria and diameter 
measurement protocols. Due to the low proportions of women, the resulting evidence is not 
necessarily generalizable to a female AAA population, which has been shown to feature a 
markedly increased rupture risk compared with male counterparts (21,41). While it has been 
shown that the rupture rate for female patients with an AAA of 4.5 cm is similar to that of a 
male patient with a 5.5 cm AAA, female patients with AAA also generally show higher 
perioperative mortality than males, why a compromise of a 50 mm as surgical threshold for 
female patients has been proposed in recent guidelines (2,3). Before surgery is performed, 
cardiac, pulmonary, renal and nutritional statuses are evaluated and optimized. The patients 
should also be started on statins several weeks preoperatively (3).   
 
Table 1: Summary of randomized controlled trials comparing surveillance to surgery 
in small AAAs.  
Attribute UKSAT ADAM PIVOTAL CAESAR 
Diameter, inclusion 
range 
4-5.4 cm 4-5.4 cm 4-5 cm 4.1–5.4 cm 
Ages, min-max 60-76 y.o. 50-79 y.o. 40-90 y.o. 50-79 y.o. 
Female patients 
included 
17.2% 0.8% 13.3% 4.2% 
Diameter definition US 
Antero-Posterior, 
Outer-to-Outer 
CT 
Maximal cross-
sectional diameter 
in any direction. If 
aneurysm was 
tortuous, it was 
measured 
perpendicularly to 
tortuosity 
CT CT 
Maximum external 
cross-sectional 
measurement in 
any direction but 
perpendicular to 
the vessel axis 
Protocol for 
surveillance in non-
surgery group 
US. 4 to 5 cm; 6 
months intervals, 5 
to 5.5 cm; 3 
months intervals 
US. 6 months 
intervals 
CT or US. 6 
months intervals 
US: 6 months 
intervals and CT: 
1 year intervals 
 
18 
1.1.4 Non-surgical management and timing of surgery 
The only treatment to prevent the growth and rupture of an AAA is surgery (2,32,36). The 
rate of diameter growth is positively associated with smoking and negatively with diabetes 
mellitus (21). The cessation of smoking is therefore advised to slow the progression of the 
AAA towards rupture and to decrease operative risks (2,3). This could be considered the only 
available non-surgical intervention for AAA, which makes the study of the biological effects 
of smoking highly relevant. While the mortality of a AAA rupture is striking, an elective 
aortic operation is a high-risk procedure with mortality rates at around 2-3% in contemporary 
Sweden (17). This fact calls for some sort of risk stratification when surgery is considered. 
The risk of rupture increases with the diameter of the aneurysm and this measurement is used 
as indication for surgery (18–20)  
 
Four RCTs demonstrated no benefit of operating patients with an AAA < 55 mm in diameter, 
as opposed to repeated diameter measurements (‘surveillance’, see below) until the diameter 
reaches 55 mm, Table 1 (37–41). The first two of these trials, the ‘United Kingdom Small 
Aneurysm Trial’ (UKSAT) and the ‘Aneurysm Detection and Management Veterans Affairs 
Cooperative Study’ (ADAM), compared open aortic repair (OAR) to surveillance of AAAs 
of between 4 and 5.5 cm in diameter (37,38). The two following studies ‘Comparison of 
Surveillance Versus Aortic Endografting for Small Aneurysm Repair’ (CAESAR) and the 
Positive Impact of Endovascular Options for treating Aneurysms Early (PIVOTAL) instead 
studied endovascular aneurysm repair (EVAR) in small AAAs compared with surveillance 
(39,40). These studies shared similar diameter thresholds for intervention, surveillance time 
intervals and included few women. Differences include age criteria and diameter 
measurement protocols. Due to the low proportions of women, the resulting evidence is not 
necessarily generalizable to a female AAA population, which has been shown to feature a 
markedly increased rupture risk compared with male counterparts (21,41). While it has been 
shown that the rupture rate for female patients with an AAA of 4.5 cm is similar to that of a 
male patient with a 5.5 cm AAA, female patients with AAA also generally show higher 
perioperative mortality than males, why a compromise of a 50 mm as surgical threshold for 
female patients has been proposed in recent guidelines (2,3). Before surgery is performed, 
cardiac, pulmonary, renal and nutritional statuses are evaluated and optimized. The patients 
should also be started on statins several weeks preoperatively (3).   
 
Table 1: Summary of randomized controlled trials comparing surveillance to surgery 
in small AAAs.  
Attribute UKSAT ADAM PIVOTAL CAESAR 
Diameter, inclusion 
range 
4-5.4 cm 4-5.4 cm 4-5 cm 4.1–5.4 cm 
Ages, min-max 60-76 y.o. 50-79 y.o. 40-90 y.o. 50-79 y.o. 
Female patients 
included 
17.2% 0.8% 13.3% 4.2% 
Diameter definition US 
Antero-Posterior, 
Outer-to-Outer 
CT 
Maximal cross-
sectional diameter 
in any direction. If 
aneurysm was 
tortuous, it was 
measured 
perpendicularly to 
tortuosity 
CT CT 
Maximum external 
cross-sectional 
measurement in 
any direction but 
perpendicular to 
the vessel axis 
Protocol for 
surveillance in non-
surgery group 
US. 4 to 5 cm; 6 
months intervals, 5 
to 5.5 cm; 3 
months intervals 
US. 6 months 
intervals 
CT or US. 6 
months intervals 
US: 6 months 
intervals and CT: 
1 year intervals 
20
  19 
Threshold for 
surgery 
Diameter ≥ 5.5, 
symptomatic 
AAA, growth rate 
≥ 1cm/y or 0.7 cm 
/ ½ y 
Diameter ≥ 5.5, 
symptomatic 
AAA, growth rate 
≥ 1cm/y 
Diameter ≥ 5.5, 
symptomatic 
AAA, growth rate 
≥ 0.5 cm/ ½ y 
Diameter ≥ 5.5, 
symptomatic 
AAA, growth ≥ 
1cm/y 
Primary Outcome All-cause 
mortality 
All-cause 
mortality 
Aneurysm-related 
mortality after 3 y 
All-cause 
mortality 
Result No difference in 
primary outcome 
No difference in 
primary outcome 
No difference in 
primary outcome 
No difference in 
primary outcome 
Authors’ 
interpretation 
Survival not 
improved by 
surgery of small 
AAAs 
Survival not 
improved by 
surgery of small 
AAAs 
Early EVAR and 
surveillance are 
both safe 
alternatives for 
patients with small 
AAAs 
Surveillance is 
safe for small 
AAAs 
Abbreviations; AAA: Abdominal aortic aneurysm, UKSAT: United Kingdom Small Aneurysm Trial, 
ADAM: Aneurysm Detection and Management Veterans Affairs Cooperative Study, CAESAR: Comparison 
of Surveillance Versus Aortic Endografting for Small Aneurysm Repair, CT: computed tomography, 
EVAR: endovascular aneurysm repair, PIVOTAL: Positive Impact of Endovascular Options for treating 
Aneurysms Early, US: ultrasound, y.o.: years old 
 
1.1.5 Open and endovascular surgery 
 
Two principal surgical treatments exist; OAR or EVAR. Laparoscopic aneurysm repair has 
been described but is associated with an increased risk of serious adverse events and is not 
recommended (3,42). An OAR is performed either by transperitoneal or left retroperitoneal 
incision, both of which show similar outcomes in RCTs (43). The commonly used 
transperitoneal approach is versatile and allows access to all abdominal organs, whereas the 
retroperitoneal approach offers better exposure of the suprarenal aorta, facilitates repair of 
inflammatory AAA or that associated with a horseshoe kidney while allowing the surgeon to 
avoid a hostile abdomen (2,3). After exposure of the AAA, OAR proceeds by suturing a tube-
shaped or bifurcated synthetic graft into the aorta, after which the aneurysm sac is wrapped 
around it to prevent viscera adhering and potentially forming fistulas against the 
reconstructed aorta.  
 
The most common treatment modality of AAA in Sweden is EVAR (17). In EVAR, access 
to the circulation is obtained via the femoral arteries after which a stent graft is inserted into 
the aorta (Figure 3). Thus, blood flows through the stent graft and pressure is removed from 
the aneurysm vessel wall. So called endoleaks are important EVAR-specific complications 
where for different reasons, opposite to what is intended, blood flows between the stent graft 
and the vessel wall of the aneurysm sac (44). Endoleaks are divided into four classes; type I 
indicates leakage of blood at proximal or distal attachment sites, type II is retrograde flow 
from aortic branches, type III is leakage at defects in the stent graft wall or in a junction 
between stent grafts and type IV indicates leakage through the stent graft due to fabric 
porosity. Type I or III occur in 1-5% of patients and expose the aneurysm to pressurized 
circulation which necessitates prompt reintervention (2,3). Type II endoleaks occur in around 
20% of patients and can be considered benign if not associated with persistent aneurysm 
growth (2,3). Other complications include endotension (“type V endoleak”; increasing 
aneurysm sac size despite no demonstrable leak on imaging), migration, kinking and limb 
occlusion. Due to these complications, patients treated with EVAR are typically required to 
undergo imaging surveillance, often by CTA, at regular intervals for the rest of their lives, 
which is not required after OAR. 
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A number of RCTs have compared 
outcomes of OAR and EVAR for 
treatment of asymptomatic and 
ruptured AAA (45–54). The trials 
EVAR-1 (49), OVER (50), DREAM 
(48) and ACE (47) compared OAR 
with EVAR for the treatment of 
asymptomatic AAAs. A recent meta-
analysis of these trials showed that the 
mortality was lower with EVAR in the 
short term but within 3 years, the 
survival after EVAR and OAR was the 
same after which the aneurysm-related 
mortality was higher in the EVAR-
group compared with OAR, although 
one of the included studies showed no 
difference (45,47–50). The current 
recommendation of the European 
Society for Vascular Surgery is to make 
individual patient-specific decisions of 
OAR vs EVAR but that EVAR should 
be considered the first-hand choice in patients with anatomically suitable AAAs, due to its 
early mortality benefit and the 9 years post-operative survival of the average AAA patient 
(3). In contrast, the United Kingdom’s National Institute for Health and Care Excellence 
(NICE) did not consider EVAR cost-effective and based on formal analyses of above RCTs 
instead recommends OAR as the first-hand choice (55).  
 
The AJAX (52), IMPROVE (53) and ECAR (54) RCTs compared EVAR with OAR for 
ruptured AAAs. The study designs differed as AJAX and ECAR only considered patients for 
randomization if the anatomy of their aneurysms allowed EVAR. Conversely, IMPROVE 
aimed to compare open and endovascular strategies, randomizing patients before the anatomy 
was known to an endovascular strategy (EVAR or OAR based on anatomy) or an open 
strategy (only OAR). There were no differences in overall 30-day mortality between the 
groups but a meta-analysis observed that at 90 days, EVAR seemed to benefit women and 
that patients treated with EVAR required shorter hospital stays (46). Further supporting the 
use of EVAR to treat ruptured AAA, long-term results from IMPROVE showed a lower 
three-year mortality and higher early quality of life in patients treated with EVAR compared 
with OAR (56).  
 
The EVAR-2 RCT compared EVAR with no intervention in patients with AAA who reached 
indication for surgery but were considered too frail for OAR (57). It was shown that there 
was no difference in aneurysm-related mortality during the first four years, whereas there 
was decreased aneurysm-related mortality in the EVAR group at later time points. There was 
no difference between the groups in all-cause mortality. During the course of the trial, 9 
patients in the EVAR group suffered rupture before the intervention occurred and, further, ca 
30% of patients assigned to no intervention underwent elective AAA surgery nevertheless, 
complicating and limiting the interpretation of the results. 
 
1.1.6 Surveillance and management of patients with small AAAs 
 
When patients are diagnosed with an AAA that is smaller than the surgical threshold, they 
are enrolled into a surveillance program. The frequency of surveillance is determined by the 
Figure 3. Endovascular aneurysm repair (EVAR). By 
the National Institutes of Health, Public Domain.  
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aneurysm diameter, and the patient’s aneurysm is measured repeatedly with regular intervals 
until it reaches the surgical threshold (2,3). The rate of diameter growth correlates with the 
diameter (18–20,58). A large meta-analysis which included heterogenous studies on patients 
under surveillance used sophisticated statistical models, which considered individual 
variation, measurement errors, different imaging modalities and separate growth rates for 
men and women, in order to determine safe surveillance intervals (58). It recommended safe 
intervals with respect to the probability of reaching 55 mm and, for men, the risk of rupture. 
While the growth rates of men and women were similar, the time to reach a 1% risk of rupture 
was much shorter in women and the authors supported the already existing recommendation 
to treat female AAA patients at smaller diameter while noting that their risk of perioperative 
mortality was higher.  
 
Currently, diameter measurements are recommended, preferentially by US, every 3 years for 
AAAs 3-3.9 cm, every year for AAAs 4-4.9 cm and every 6 months for AAAs ≥ 5.0 cm (2,3). 
However, the correlation between the baseline diameter and subsequent growth rate is weak 
and it is difficult to predict the trajectory of an individual patient, resulting in many US 
examinations required not to miss the few aneurysms that will grow rapidly (59,60). Further, 
although this protocol is maintained, a small but existing risk of rupture during surveillance 
remains (61–64). In above mentioned meta-analysis, 1.6% of men and 3.8% of women under 
surveillance suffered from ruptured AAA, the risk of which increased with increasing 
diameter (58). Research on the link between sex and AAA is elaborated on in section 1.2.9. 
 
1.1.7 Global outlook 
 
Creating more precise surveillance protocols, gaining a better understanding of 
pathophysiology and developing future medical treatments would have major implications 
for the health of patients with AAA globally, including in societies hitherto underserved by 
vascular surgery. Life expectancy as well as the incidence and prevalence of non-
communicable diseases, including cardiovascular disease, are increasing globally (Figure 4) 
(65–68). The increasing prevalence of cardiovascular disease in low- and middle-income 
countries (LMIC) can be attributed to increasing life expectancy as well as an increased 
exposure to behavioral and metabolic risks previously more common in high-income 
countries (68). However, infectious and environmental risk factors for cardiovascular 
disease, as well as untreated congenital conditions, remain uncorrected in the poorest parts 
of the World, resulting in additional risk of morbidity and mortality (68). Further, the 
underreporting of cardiovascular disease, especially peripheral arterial disease (PAD), is an 
important impediment to research (65).  
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Figure 4: Global life expectancy and tobacco smoking. Data from the World bank and Gapminder. 
Global life expectancy: each line represents one nation.   
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Surgery has until recently been a relatively underrecognized aspect of global health. In order 
to address this gap of knowledge, a Lancet commission on global surgery was formed in 2014 
and highlighted five key messages: 5 billion people lack access to safe and affordable surgery 
and anesthesia, an excess of 140 million additional surgical procedures are required in 
LMICs, a quarter of people who received surgical care face catastrophic expenditure as a 
result, improving surgical coverage in LMICs is cost-effective and finally that surgery is an 
indispensable part of health care (69). Global Surgery is now a rapidly evolving and 
increasingly recognized discipline. However, while global surgery has been the unrecognized 
field of global health, vascular surgery is the unrecognized field of global surgery. Vascular 
surgery is barely mentioned in the report by the Lancet commission and while prevalence of 
PAD is high and increasing, especially in LMICs, studies suggest that vascular procedures 
and amputations are performed infrequently and in some settings more often for trauma than 
for PAD (69,70).  
 
Surgery of AAA requires resources that are scarce in large proportions of the world. Such 
necessities include access to blood, anesthesia, intensive care and if EVAR is considered, 
interventional angiography suites and repeated post-operative surveillance (2,3,69). The 
disease is asymptomatic until rupture occurs and rupture causes death rather than a resource-
demanding disability, preferentially in elderly members of society, creating small cost 
incentives to prioritize treatment of AAA. As such, and without a working medical treatment, 
the diagnosis of AAA is of little use to a patient who lives in a setting were the above-
mentioned infrastructure is missing or inaccessible. Further, the diagnosis itself requires 
imaging technologies such as US and CT. These reasons cause an underestimation of global 
AAA prevalence. The true prevalence of AAA, however, is likely to rise due to increasing 
age and pervasiveness of smoking, hypertension and hyperlipidemia (65,68).  
 
These issues can be attacked from several different angles. In addition to crucial investments 
in surgical and anesthesiologic infrastructure and providers, increased capability of LMICs 
to diagnose and treat PAD would be required to meet future needs (69,70). With AAA 
specifically, improving the specificity and increasing the simplicity of diagnosis and 
surveillance algorithms, as well as the development of pharmaceutical agents to decrease the 
diameter growth rate and prevent rupture, would greatly lower the bar for adequate care in 
low-resource settings.  
 
1.1.8 A brief history of abdominal aortic aneurysm 
 
The first known complete description of the systemic circulation of blood by the beating heart 
was provided by William Harvey in 1628, before which the respiratory and circulatory 
systems were considered to be continuous (71). The first preserved account of aneurysms can 
be found as early as in the Papyrus Ebers (Figure 5), an Egyptian scroll describing diseases 
and remedies from around 1550 BC, which is thought to be based on even earlier literature 
(72). The physician Galen and the surgeon Antyllus, both of Greek origin active in Rome in 
the second century AD, also mentioned aneurysms in their writings and the latter described 
an operative technique comprising proximal and distal ligation, central incision of the 
aneurysm, and evacuation of the intraluminal thrombus. This method was used for the next 
1000 years (73).  
 
Early development of surgery for AAA beyond simple ligation was undertaken in the 
eighteenth and nineteenth centuries, as their natural course was described, retroperitoneal 
aortic exposure was conceived and endovascular repair by use of coiling was attempted. In 
the end of the nineteenth century, electricity was used to try to thrombose the aneurysm by 
letting current pass through the packing wires (73). A method tried in early twentieth century 
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Early development of surgery for AAA beyond simple ligation was undertaken in the 
eighteenth and nineteenth centuries, as their natural course was described, retroperitoneal 
aortic exposure was conceived and endovascular repair by use of coiling was attempted. In 
the end of the nineteenth century, electricity was used to try to thrombose the aneurysm by 
letting current pass through the packing wires (73). A method tried in early twentieth century 
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by Rudolf Matas was ‘endoaneurysmorraphy’ where the aneurysm was opened and plicated 
over a catheter which was removed before closing (74). The reinforcement of an aneurysm 
by wrapping its outside with cellophane was later proposed by Rea and used to by Rudolf 
Nissen to treat the likely symptomatic AAA of Albert Einstein which ruptured five years post 
operation in 1955 (75). These methods were not durable and important strides towards long-
lasting solutions were made when Charles Dubost performed aneurysm resection and 
interposition graft of a cadaveric aortic allograft, the complications of which were drastically 
reduced when Oscar Creech in 1966 combined this method with Matas’ 
endoaneurysmorraphy and sutured the graft in place inside the aneurysm sac without sac 
resection, thus shortening operating time and avoiding damage to adjacent structures such as 
the vena cava (76,77). The substitution of the aortic allograft with a synthetic dacron graft 
was described by DeBakey and Cooley in 1958 (78) and this method remains the standard 
procedure of OAR.  
 
The late twentieth and early twenty-first centuries saw the development and widespread 
adoption of endovascular repair of AAAs. The first publication describing a successful 
endovascular placement of an aortic graft was in 1987 by Nicolai Volodos to treat a false 
aneurysm of the thoracic aorta (79). The breakthrough of EVAR came, however, after Juan 
C. Parodi and Julio Palmaz in 1991 published a case series of 5 patients with AAA on whom 
the endovascular placement of an aortic stent-graft was performed (80). In subsequent years, 
the care of patients with AAA was given a strong evidence base as the diameter threshold for 
surgical repair, surveillance intervals, screening for AAA and outcomes after OAR and 
EVAR were established through landmark randomized trials, described above (30,31,33,37–
40,49,50,52–54,64).  
Figure 5. The Papyrus Ebers. By user Einsamer Schütze 
licensed under CC-BY-SA-3.0,2.5,2.0,1.0.  
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1.2 PATHOPHYSIOLOGY 
 
1.2.1 The normal aorta  
 
The aorta is the body’s major blood vessel and courses from the left ventricle of the heart, in 
a thoracic arch and descends into the abdomen where it bifurcates into the iliac arteries 
(Figure 6A). The normal aorta is an elastic artery that consists of intimal, medial and 
adventitial wall layers (Figure 6B). In simple terms, the infrarenal aorta consists of around 
36% collagen, 23% vascular smooth muscle cells (vSMC), 23% elastic fiber and 18% ground 
substance by dry weight (81). 
 
The aortic intima consists of a monolayer of glycocalyx-covered endothelial cells adhering 
to a basement membrane and loose connective tissue, separated from the media by an internal 
elastic lamina. The endothelium is the inner lining of the vascular system and plays an active 
role in the maintenance of vascular homeostasis and health. It regulates the tone of the vSMCs 
in the underlying media, is selectively permeable to cells and macromolecules while 
maintaining a non-thrombogenic surface against circulating blood. Glycocalyx refers to the 
negatively charged glycoproteins and proteoglycans of the endothelial cell membrane which 
appear to have atheroprotective effects and if the glycocalyx is damaged, increased 
permeability, platelet aggregation and decreased vascular responsiveness have been shown 
to follow (82). The endothelium senses changes in biomechanical forces such as shear stress 
and tensile stress / cyclic stretch by means of mechanoreceptors, which, in addition to the 
production of NO that relaxes underlying vSMCs and inhibit platelet aggregation and 
thrombosis, results in production of other vasoactive agents, growth factors, cytokines and 
affects its permeability (82). The endothelial cells are able to produce elastin and may 
contribute to the formation of the inner elastic lamina (83). Components of the basement 
membrane include collagen types IV, XV, XVIII as well as laminins, perlecan and agrin (83–
85). 
 
Figure 6: The normal aorta. A: Aortic branches. B: Basic histology of the aorta. 
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The three-dimensional (3D) structure of the aortic media is complex, with circumferentially 
oriented elastic lamellae and their radial protrusions, connected via radial intralamellar elastic 
struts, interspersed with dense collagen fibers and ground substance tightly interwoven with 
vSMCs, all of which are mainly oriented in the circumferential direction (86). The 
differentiated vSMC is contractile and typically express markers related to the contractile 
machinery such as smooth muscle alpha actin, myosin-11 and smoothelin (87). However, the 
vSMC have been shown to be highly plastic and may de-differentiate in changing conditions 
(such as an injury) to a less contractile, more synthetic and proliferative phenotype, even 
transdifferentiating into macrophage-like cells, with emerging significance in several 
diseases (87). The vSMCs are important to actively distribute stress among aortic wall 
components and to maintain extracellular matrix (ECM) structure and homeostasis by 
producing structural proteins and matrix-degrading enzymes (88). However, they do not 
appear to affect the passive mechanics of large, elastic arteries (89). These properties arise 
from the complex, layered ECM and should include elasticity and compliance so that the 
aorta distends during systole and recoils in diastole, dampening blood pressure fluctuations 
and maintaining continuous blood flow, with minimal energy loss, but the aorta should have 
high strength and its rate of stiffening should also increase with increasing pressure (non-
linearly) to avoid rupture. Key constituents include elastic laminae, collagens and 
proteoglycans (83). The elastic fibers, which are complex structures consisting of 
polymerized tropoelastin surrounded by microfibrils and over 30 different associated proteins 
assembled in an intricate, step-wise manner, are highly distensible and yield low tensile 
strength but lends the aorta its elasticity (83,90,91). Main proteins associated with the elastic 
fiber are elastin, fibrillins, fibulins, emilins etc as well as lysyl oxidase which cross-links the 
tropoelastin monomers into polymers (91). Importantly, while its production is tightly 
regulated during development, elastin is generally not replaced thereafter, and the classic 
view has been that the same elastic fibers need to last throughout the lifetime of the aorta 
(92). The elastic fibers are indirectly connected to the contractile machinery of the vSMC 
and these form together a contractile unit which can respond to aortic stress (88). Collagens 
are present throughout the aortic wall and generally provide stiffness and strength. Many 
types of collagens exist and they may be fibril forming, such as types I, II, III and V, while 
types IV, VIII and X form networks (93). Collagen IV is the major structural protein of the 
basal lamina. The distribution of main arterial collagens I, III and IV differ depending on the 
aortic region; in the fetal bovine abdominal aorta types I and IV mainly localize to the intima 
and media wall layers, whereas type III localizes to adventitia. The turnover rate of collagen 
in the normal aorta far exceeds that of elastin (92,94). Ground substance refers to the non-
fibrous aspect of the ECM, where proteoglycans with covalently attached 
glycosaminoglycans are important constituents. Large proteoglycans present in the aortic 
wall include versican and aggrecan, which bind the major glucosaminoglycan hyaluronan 
(83,85). Small leucin rich proteoglycans such as decorin, biglycan and lumican bind to other 
structural ECM components rather than glucosaminoglycans and are involved in 
fibrillogenesis but expanding literature also suggests roles in cell growth, differentiation and 
inflammation (83,85). Vascular glycoproteins include fibronectin and vitronectin, of which 
the former is well studied with important roles in adhesion, migration, growth and 
differentiation (95). Biomechanically, ground substance on a whole is insufficiently studied 
but seems to contribute to aortic mechanics, particularly ‘residual stress’ (96), which can be 
explained as the stress a solid material imparts on itself when external stressors are removed. 
The importance of ground substance and residual stress has long been recognized in for 
example cartilage tissue (97).  
 
The adventitia is delineated by the outer elastic lamina of the media and encompasses 
collagen-rich ECM, fibroblasts, immune cells, vasa vasora, lymph vessels and nerves, which 
gives it high tensile strength and prohibits overstretching of the vessel, but also makes it 
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capable of responding to insults with fibrosis and recruitment of innate and adaptive immune 
cells (98). The fibroblast is responsible for the production of the strong ECM but have also 
been shown to be among the first cells to respond to insult, with activation, participation in 
ECM remodeling and expression of pro-inflammatory molecules (99). Further, the phenotype 
of a fibroblast may be altered into that similar to a vSMC (becoming a ‘myofibroblast’), 
including the expression of contractile markers, making it impossible to safely distinguish 
fibroblasts and vSMCs by simple marker histology (99). Immune cell residents of the normal 
adventitia include macrophages and dendritic cells which, together with fibroblasts, are able 
to trigger an inflammatory response and may propagate centripetally (99).  
 
There is significant anatomical heterogeneity of embryology, structure, physiology and 
susceptibility to disease along the length of the aorta, despite its appearance of a continuous 
and homogenous conductive tube. The vSMCs of different aortic segments arise from diverse 
embryologic origins, and boundaries have been approximated such that the thoracic aorta 
arise from neural crest cells (ascending and arch) and somites (descending) while the 
abdominal aorta originates from splanchnic mesoderm (100). Further, these cells appear to 
retain lineage-specific phenotypic characteristics, for example responding differently to 
transforming growth factor beta (TGF-β), with implications for clinical TGF-β-related, 
familial aneurysm-causing conditions such as Loeys-Dietz and Marfan syndomes, which 
more commonly affect the thoracic aorta (101–104). After development, the mature thoracic 
aorta has around 60 layers of medial elastic laminae and a thick vessel wall with a media 
supported by vasa vasorum. In contrast, the abdominal infrarenal aorta conveys a smaller 
blood volume, since the kidneys take up a significant share of it. As a result, it has a smaller 
diameter, half as many (around 30) medial elastic laminae and feature few medial vasa 
vasorum which makes it dependent on transintimal supply of oxygen and nutrients provided 
by the aortic intraluminal blood flow (105). In patients with AAA, the prevalence of 
concurrent thoracic aortic aneurysm is 28% in total with male prevalence for ascending and 
descending aneurysm being 2.2 and 21%, respectively. Female patients with AAA appear to 
have more aggressive generalized aneurysm disease with corresponding numbers of 7.5% 
and 46% (29).  
 
1.2.2 Atherosclerosis and aneurysm: two distinct conditions with overlapping 
risk factors 
 
While the common, degenerative, AAA has been colloquially referred to as an 
‘atherosclerotic’ aneurysm, this term is only half correct. Indeed, atherosclerotic occlusive 
disease shares many risk factors with AAA, such as age, hypertension and smoking (106–
108). Female sex and particularly endogenous estrogen appear to have a protective effect 
against both conditions (109,110) and, further, PAD is in itself an independent risk factor for 
AAA (108). There is however clinical, histopathological (Figure 7) and genetic evidence to 
classify atherosclerosis and AAA as distinct conditions. Clinically, diabetes mellitus is an 
important driver behind coronary artery disease (106) and aortic occlusive disease (107) 
whereas it, on the contrary, appears to be protective against AAA prevalence (108) and 
growth (21). A potential confounder is the use of metformin, which has been proposed as a 
potential drug target against AAA (111). The histopathological pattern of an atherosclerotic 
artery is characterized by cholesterol accumulation, inflammation and necrosis that is almost 
exclusively confined to the tunica intima. In contrast, microscopic evaluation of AAA tissue 
reveals transmural inflammation with extensive loss of elastic laminae, apoptosis of vSMCs 
and extensive fibrosis resulting in a thoroughly altered vessel wall structure, compared to the 
normal artery (112). Finally, the two vascular diseases share some single nucleotide 
polymorphisms (SNP) but appear to feature distinct gene expression patterns (113,114).  
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Figure 7: Histopathological characteristics of normal aorta, abdominal aortic aneurysm and 
atherosclerosis. Left column: schematic diagram of histolpathological characteristics. Right column: 
Masson’s trichrome stains of normal abdominal aorta, abdominal aortic aneurysm and carotid 
atherosclerosis showing the distribution of cytoplasmic contents (red), fibrous connective tissue (blue) 
and cell nuclei (black).  
Abbreviations; ILT: intraluminal thrombus, ECM: extracellular matrix 
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1.2.3 Extracellular matrix  
 
Disruption of the medial extracellular matrix is one of the most striking features of aneurysm 
disease and is characterized by fragmentation of elastin, collagen turnover, reduction of 
ground substance and apoptosis of vSMC. Specifically, elastin concentrations are lower and 
elastase activity is higher in AAAs than in both normal and heavily atherosclerotic aortas, 
the latter from patients of similar age (114–116). The loss of elastin is accompanied by a 
mechanical compensation by increased production and deposition of collagen, mainly type I 
and III, by adventitial fibroblasts (81). However, the turnover rate of collagen in aneurysms 
is increased and the newly produced collagen does not orient in a layered structure as in a 
normal aorta and, further, display signs of impaired crosslinking (117–119). Consequently, 
it may be reasonable to assume that the fibrosis observed in AAA is protective and increases 
aneurysm strength to counter increasing stress but that the fibrillar quality and structure is 
hampered, predisposing the natural course to rupture. The significance of elastolysis and 
collagenolysis has been studied by injecting elastase and collagenase into canine aortas. It 
was found that degradation of elastin caused aneurysmal dilatation of the aorta but that the 
aortas did not rupture until the collagen was degraded as well (120). These results imply that 
dilatation, stiffening and widening of the aorta is caused by disruption of the elastic laminae 
but that imbalanced collagen turnover may underlie the occurrence of rupture. This 
hypothesis agrees with the material properties of elastin and collagen, which are 
characterized by high compliance and tensile strength, respectively. The loss of elastic 
laminae and the subsequent increase of collagen deposition are manifested by an increase in 
aortic stiffness associated with age and, to an even higher extent, with AAA (121,122).  
 
Ground substance, ie proteoglycans, glucosaminoglycans and glycoproteins, is 
pathologically remodeled in AAA disease but studied to a lesser extent (81). Proteoglycans 
previously linked to aneurysm disease include potentially protective syndecan (123), 
biglycan (124), mast cell secretory granule-associated serglycin and collagen XV, which has 
been associated with severity of thoracic aortic aneurysm (125), collagen XVIII, which is a 
circulating marker of AAA diameter (126) and decorin, which when substituted can attenuate 
dissecting aneurysms in mouse models (127). Large proteoglycans versican and aggrecan 
have been shown to be decreased in AAA (128). The glycoprotein fibronectin is a 
fundamental ECM protein which is increased in AAA (128). Mouse experiments of 
atherosclerosis show that plasma fibronectin-deficiency decreased atherosclerotic plaque 
size, number and leukocyte recruitment but that lesions in the fibronectin-deficient mice also 
lacked a protective fibrous cap (129). Aberrant splicing of fibronectin has been suggested as 
a contributing factor to bicuspid valve-associated thoracic aneurysms (130). 
 
Several molecular and cellular mechanisms important for the aneurysmal destruction of 
normal vessel architecture have been identified. On the enzyme level, matrix 
metalloproteases (MMPs) and cathepsins have been implied as culprits in aneurysm disease, 
while the inhibitors, referred to as tissue inhibitors of metalloproteases (TIMPs) and cystatin 
C, respectively, are putatively protective. The collagenases MMP-1 (‘interstitial 
collagenase’), MMP-2 (‘gelatinase A’), MMP-8 (‘neutrophil collagenase’), MMP-9 
(‘gelatinase B) and MMP-13 (‘collagenase 3’), the elastolytic MMP-12 (‘macrophage 
metalloelastase’) as well as MMP-3 (‘stromelysin 1’), the latter able to degrade collagens, 
ground substance and elastin, have all been suggested as effectors of medial destruction 
(119,131–133). However, importantly, MMPs are produced in latent form and the level of 
enzymatic activity does not directly correspond to expression of the MMP gene or zymogen 
(132). Plasmin is able to activate MMPs but can also degrade pericellular proteins, such as 
fibronectin. Cathepsins are potent proteases that are primarily active in acidic pH, such as in 
endosomes and lysosomes, but have been shown to remain active in the extracellular matrix, 
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1.2.3 Extracellular matrix  
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given an acidic pericellular environment (134). Cathepsins K, L and S are increased in AAA 
and cathepsins B, K and S are increased in cerebral aneurysms (135). Some of these peptides, 
in zymogen or enzyme form, are also increased in the peripheral blood of AAA patients. 
Circulating MMP-9, TIMP-1, TIMP-2 as well as Cathepsins L, S and V have been shown to 
be increased in patients with AAA, compared with those without (136). Neutrophil elastase, 
granzymes as well as mast cell chymase and tryptase have also been implicated in the 
destruction of ECM and/or activation of other enzymes in AAA (137). A disintegrin and 
metalloproteinase (ADAM) and ADAM with thrombospondin motifs (ADAMTS) are 
proteolytic enzymes that have received less attention than MMPs but have been shown to be 
associated with AAA disease (138–140). Finally, neutrophil elastase can cleave elastin but 
also fibrillar collagens, fibronectin, laminin and aggrecans and activate MMPs implicating 
the infiltration of the vessel wall by neutrophils as an important pathophysiologic component 
(137).  
 
Recent efforts have been made to inhibit the ECM degradation in AAAs to reduce growth 
rates. Doxycyclin inhibits both inflammation and MMPs and the effect of this drug has been 
evaluated in three RCTs, one of which was published recently (141). Unfortunately, this 
treatment did not affect the AAA growth rate.  
1.2.4 Loss and phenotypic modulation of vascular smooth muscle cells 
 
Depletion of vSMC is another major hallmark of AAA disease. It has been demonstrated that 
AAAs contain a lower total number of vSCMs per cross-section, compared to normal aortas, 
and thus that the scarcity is not only a matter of the same amount of cells spread out on an 
enlarged vessel (142). The remaining vSMCs express markers of apoptosis (142). Several 
mechanisms behind the vSMC death have been suggested. Anoïkis, defined as the 
programmed cell death following loss of cell interactions with the underlying matrix, may be 
a factor induced in part by the degradation of fibronectin by plasmin and inflammatory cell-
derived chymase (143). Other suggested mechanisms include T-cell induced apoptosis and 
oxidative stress (142,144). 
 
The vSMC is a highly plastic cell type and can switch from a contractile to a synthetic, 
proliferative and even macrophage-like phenotype (87). This de-differentiation with potential 
for clonal expansion, for which transcription factor KLF4 has been described as central, has 
been shown to be important in experimental vascular disease by lineage tracing experiments 
in mouse models of atherosclerosis and neointima formation (145,146). Downregulation of 
contractile markers transgelin and smooth muscle alpha actin has previously been shown in 
vSMCs of a mouse aneurysm model (147). In line with these results, the vSMCs in a lineage-
tracing, murine model of dissecting aneurysms were shown to undergo clonal expansion, de-
differentiation and expression of phagocytic markers (148).  
 
1.2.5 Immunity and inflammation 
 
The AAA vessel wall is known to be infiltrated by inflammatory cells and masses of 
lymphocytes were noted upon histological examination already by Dubost et al in their 
landmark AAA resection paper in 1952 (76). This chronic aortic inflammation is believed to 
contribute to ECM destruction and vSMC apoptosis (116). The AAA adventitia and outer 
media are highly infiltrated by T- and B-lymphocytes, plasma cells, monocytes/macrophages, 
natural killer cells, and mast cells (98,116,149,150) which form activated lymphoid tissue 
within the aneurysm wall. Several of these leukocyte subsets are also concurrently increased 
in peripheral blood (151). Several indications of autoimmunity in the common, degenerative, 
AAA have been published. Infiltrating T-and B-lymphocytes express activation markers and 
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are flanked with professional and nonprofessional antigen-presenting cells. Further, plasma 
cells of the aneurysm wall are active and IgGs purified from the aneurysm wall react against 
a number of auto-proteins (149).  
 
Interferon gamma (IFNγ, IFNG) is an important regulator of immune responses with diverse 
actions on antigen processing, inflammation and autoimmunity (152). Specifically, IFNγ is 
produced by activated T-cells, NK-cells and macrophages and activates macrophages, 
increases expression of major histocompatibility complexes I and II, promote NK-cell 
activity, induces class switching in B-cells and pushes T-cells into a Th1 phenotype, ie 
increasing cell-mediated responses with macrophages and CD8 T-cells as effectors, while 
suppressing the humoral-response Th2 phenotype (152,153). The literature pertaining to the 
role of IFNγ in AAA show divergent results. In human AAA, IFNγ and Th1-cells have been 
shown to be increased in both vessel wall and peripheral blood and Th2-type phenotype and 
related cytokine IL4 were suppressed (154,155). In animal models, however, results vary 
such that IFNγ appeared protective against aneurysm in mouse models using angiotensin 
infusion (which also causes dissection) and aortic allograft transplantation (156) but instead 
promoted aneurysm in CaCl2-application (157) and elastase perfusion models (158). 
Macrophages have consistently been found in human AAA and are well-described in mouse 
models, and a cross-talk between them and T-cells involving IFNγ is likely (137).  
 
Other important pathways of inflammation investigated in AAA disease are that of NF-κB, 
IL6, and inflammasome. Stimuli of NF-κB include reactive oxygen species, hypertension and 
MMP9 while target genes include TNF, IL1, IL6, COX2 and several chemokines (159). 
Suppression of this pathway has been protective against aneurysm in animal models (159). 
The IL6 pathways can be activated either by activation of a membrane-bound or soluble 
receptor (IL6R). A common non-synonymous sequence variant of IL6R that results in 
increased cleavage of membrane-bound IL6R and therefore higher levels of IL6R in 
circulation but also decreased levels of downstream signaling has been associated with a 
lower risk of AAA in a Mendelian randomization study and a smaller aneurysm diameter in 
a recent meta-analysis (160,161). Further, while previous animal models could not see a 
strong effect of blocking IL6R generally, the latter investigation showed that specific 
intervention against the soluble receptor increased survival in two murine aneurysm models 
(159,161). Finally, the multiprotein complex known as ‘inflammasome’, which is a critical 
mediator of the innate immune system’s response to danger- or pathogen-associated 
molecular patterns, has been shown to be active in human AAA and its suppression has been 
shown to be protective in animal models (159). 
 
Many interventions against different branches of the immune system will attenuate 
experimental aneurysm formation (112). However, these models mostly focus on stopping 
the formation of, rather than treating, aneurysms that moreover are results of an extreme 
molecular insult, such as elastase perfusion, CaCl2-application and angiotensin II-infusion. 
Importantly, these results appear difficult to translate into human disease as worryingly high 
prevalence, growth and rupture rates of AAAs in association with aggressive 
immunosuppressive treatment have been observed (162,163). The only completed RCTs 
testing anti-inflammatory drugs against human AAA were those of mast cell inhibitor 
pemirolast, motivated by the protection against experimental rodent aneurysms by mast cell- 
deficiency and -inhibition (150,164), and doxycycline which has anti-inflammatory and 
MMP-inhibiting properties (141). These interventions, however, did not affect aneurysm 
growth rate (141,165).  
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1.2.6 Hypoxia, oxidative stress and angiogenesis 
 
Oxidative stress has been proposed as an important feature in AAA disease, as it is increased 
in inflammation as well as in AAA, further promotes inflammation, effects of matrix-
degrading enzymes and inducing smooth muscle cell apoptosis (144). Neutrophils, 
macrophages, endothelial cells, vSMCs and fibroblasts are capable of producing oxidant 
species which in turn may cause upregulation of chemotactic cytokines, activation of MMPs, 
and induce vSMC apoptosis via NADPH oxidase (166). Antioxidants that have been 
protective against aneurysms in experimental models include catalase, tamoxifen, reservatrol 
as well as vitamins C and E (167). Other examples of antioxidants are metallothioneins, 
which bind trace metals and are downregulated in bicuspid valve-related ascending thoracic 
aneurysms (168). Oxidative stress induced by cigarette smoke exposure has been shown to 
induce phenotypic switching in vSMCs and by blocking this pathway, experimental cerebral 
aneurysms could be attenuated (169). Additionally, the vessel wall of AAA display signs of 
hypoxia and expression of hypoxia-inducible factors (HIFs) with regulating long non-coding 
RNA H19 being able to cause matrix degradation and vSMC apoptosis (170–172). 
 
In contrast to the normal abdominal aorta (105), the AAA vessel wall exhibit angiogenesis 
with increased vasa vasorum density pronounced specifically in the outer media and the 
adventitia of the aneurysm (173). This angiogenesis is associated with inflammation (174) 
but also matrix degradation (175), making it highly relevant to aneurysm disease. 
Specifically, the formation of new vessels in the aneurysm media is dependent on proteolysis 
of extracellular matrix by MMPs, especially MMP-2 and -9, which have been described as 
central in AAA pathophysiology, are well studied in this regard (175). Indeed, high levels of 
medial neovascularization have been observed at the site of rupture (176). It is highly likely 
that angiogenesis facilitates recruitment of inflammatory cells to the vessel wall and is 
directly and indirectly involved in mechanical weakening of the same. 
1.2.7 Other signaling pathways 
 
Transforming growth factor beta (TGF-β, TGFB) is an important regulator of several 
biological processes such as immune and stem cell regulation and differentiation. Signaling 
typically occurs when TGF-β ligands such as TGFB1, -2 and -3 binds to receptors TGFBR1, 
-2 and co-receptor -3 and proceeds downstream with SMAD-dependent, ‘canonical’, or 
SMAD-independent, ‘non-canonical’, pathways (159). Mutations in TGF-β-related signaling 
can cause hereditary aneurysm disease, chiefly Loeys-Dietz syndromes, making it an 
interesting pathway to study in AAA as well (177). Some TGF-β-related genes are 
downregulated in human AAA (178) and rodent models have indicated a protective role of 
overexpression of TGF-β signaling, while its inhibition worsens experimental aneurysms 
(159,179). Cellular effects of TGF-β includes increased elastin synthesis by vSMCs, 
increased collagen synthesis by fibroblasts along with decreasing MMP9 and macrophage 
activity (159). Along those lines, and in line with emerging evidence of phenotypic switching 
in aneurysm pathogenesis, a recent study demonstrated that SMC-specific TGFB-deletion in 
mice prone to atherosclerosis caused aneurysms and dedifferentiation of subsets of 
contractile SMCs (180).  
 
Other signaling pathways examined in AAA include Notch and mitogen-activated protein 
kinase (MAPK). Notch signaling is highly evolutionarily conserved and acts via cell-cell 
communication between juxtaposed cells on a vast number of biological processes such as 
development, including that of vasculature, heart and blood cells, as well as homeostasis with 
tasks such as regulation of vSMC plasticity, sprouting angiogenesis, B-cell differentiation 
and T-cell production (181). While human data is contradictory, suppression of Notch 
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signaling is protective in angiotensin II mouse models of aneurysm/dissection (159). MAPK 
is another hugely diverse signaling pathway which can be activated by growth factors, 
cytokines, hormones or cellular stress and regulates processes such as proliferation, 
differentiation, survival and death (182). The MAPK family comprises kinases Jun amino-
terminal kinases (JNK), p38 and extracellular signal-related kinases (ERK). JNK is increased 
in human AAAs and its inhibition protects against experimental aneurysm, with decreased 
degradation and increased biosynthesis of ECM among proposed mechanisms. Similarly, 
ERK is increased in human AAA and can be knocked-out to prevent aneurysm in mouse 
models (159).  
1.2.8 Effect of smoking  
 
Smoking is a strong clinical risk factor for developing AAA, exhibiting a clear dose-response 
relationship (8). Importantly, this dose-response relationship also extends to cessation of 
smoking in that a decreasing odds ratio of developing AAA is seen with increasing time after 
quitting. Causality is further supported by a Mendelian randomization study demonstrating a 
strong association between AAA and genetic variations that predispose an individual to 
smoke (183). Cell experiments searching a mechanistic explanation have shown that cigarette 
smoke extract (CSE) causes decreased collagen and increased MMP production in vSMCs, 
with the latter being true also for inflammatory cells (184). It has also been shown that 
conditioned media from CSE-stimulated macrophages stimulate MMP2 and -9 expression in 
vSMCs and endothelial cells as well as the phosphorylation of JAK2 and STAT3 (185). 
Blocking JAK3/STAT3 appears to inhibit experimental aneurysm formation (186). While 
soluble smoke particles increased proliferation and survival of vSMCs, this may be in 
accordance with emerging hypotheses of phenotypic switching as a mechanism behind AAA 
(145,180,187). Further, vSMCs exposed to CSE expressed increased NADPH-oxidase, 
reactive oxygen species, proinflammatory and matrix remodeling genes while expression of 
markers of the contractile phenotype decreased. In this experiment, CSE caused increased 
formation and rupture of cerebral aneurysm in mice, whereas blocking NADPH oxidase 
diminished this effect, leading the authors to conclude that smoking can cause cerebral 
aneurysms by oxidative stress-dependent phenotypic modulation of vSMC (169). While cell 
experiments can give mechanistic information, limiting assumptions reviewed in (184) 
include that the toxin mixture would elicit the same response when applied in vitro as when 
inhaled in vivo, that the response is similar in a culture as in a complex in vivo environment 
and that this exposure would activate known pathways. A process in which inhalation of 
smoke triggers reactions in other organs that affects the aorta in a second stage is a feasible 
hypothesis.  
 
A rigorous investigation showed in 2013 that tobacco smoke exposure exacerbated elastase-
induced AAA in mice, even after a smoke-free interval up to six weeks before elastase 
perfusion, and that this exacerbation could not be stopped by MMP-inhibition by doxycycline 
or the genetic knock-out of MMP9, MMP12, Cathepsin S or Neutrophil elastase (188). 
Instead, the number of T-lymphocytes increased in smoke-exposed animals and smoke-free 
animals receiving leukocyte preparations from smoke-exposed animals exhibited an 
exacerbation of elastase-induced aneurysm, suggesting that durable effects of smoking on 
immune cells may partake in the pathogenesis of AAA. It seems reasonable, given the strong 
clinical association and indication of direct causality, together with in vitro and in vivo data, 
that the key to developing a working treatment against AAA could lie in the analysis of the 
effect of smoking on the abdominal aorta. Indeed, the only non-surgical intervention to 
decrease AAA prevalence, growth rate and risk of rupture appears to be the cessation of 
smoking (8,21).  
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A rigorous investigation showed in 2013 that tobacco smoke exposure exacerbated elastase-
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1.2.9 Influence of patient sex 
 
It is not yet known why women have a lower risk of developing AAA and why those that do 
have an increased risk of rupture compared with men. Several experimental studies have been 
performed to understand these findings (189). Male sex hormones seem to aggravate disease 
as male rodents with aneurysms produced by Angiotensin II-injection or local elastase 
infusion get larger and more frequent aneurysms, against which orchidectomy is protective 
unless testosterone substitution is administered (190–195). Knocking out the androgen 
receptor in vSMCs and macrophages reduces experimental aneurysm (196). Female sex 
hormones appear to be protective, as female rodents get smaller experimental aneurysms and 
estradiol treatment protects against aneurysm in male rodents (191,193,197). Further, an 
aorta from a female donor rat into a male recipient rat was not protected against aneurysm 
development by elastase perfusion (191). There is, however, conflicting evidence on the 
effect of ovariectomy on rodent aneurysm development (190,193,197). Mechanistically, 
female sex hormones have a suppressive effect on macrophage and neutrophil infiltration, 
MMP9-activation and -production, inflammatory signaling and seems to increase collagen 
and TGF-β production (192–194,197,198). Injection of mesenchymal stem cells seem to be 
protective against elastase-induced aneurysms in mice, with the strongest effect on aneurysm 
and inflammatory profile seen if the stem cells were collected from female mice (199). 
Female mice with XY chromosome complement develop severe and rupture-prone 
angiotensin II-induced aneurysms, with signs of increased inflammation and oxidative stress, 
compared to female mice without (200). The XY chromosome complement in male mice 
caused diffuse aneurysmal dilatation whereas XX complement caused focal dilatation (201). 
In vitro, MMP-9 and TIMP-1 expressions are lower in vSMCs explanted from female rat 
aortas, compared to those from male rat aortas (202).  
 
In humans, women who do develop AAA have an early menopause, which is congruent with 
above preclinical data (203). Female patients with AAA further have a clinically increased 
risk of rupture (203), which the observed sex-related differences in elastin content (204) and 
collagen cross-linking (205) may contribute to. The body surface area (BSA) of women is 
lower, on average, compared with that of men and it could be argued that the aortic dilatation 
at a specific diameter threshold is generally larger relative to the rest of the patient in women 
compared with men, explaining why smaller aneurysms in women behave like larger 
aneurysms in men (58,206,207).  
1.2.10 Genetics 
 
Aortic aneurysms can arise in the context of Mendelian or non-Mendelian forms of 
inheritance and genetic alteration. While monogenic mutations typically affect the thoracic 
aorta, some syndromes that may involve AAA include Marfan, Loeys-Dietz and Ehlers-
Danlos, resulting from mutations in FBN1, TGF-β-axis and COL3A1, respectively (208). For 
the common AAA, a large number of genetic studies have been performed and 
polymorphisms regions located in or near genes related to ECM, inflammation/immunity, 
TGF-β-pathways and those associated with cardiovascular disease have been implicated 
(209). 
 
Genome-wide association study (GWAS) is a method used to screen for common genetic 
variants (allele frequency of > 1%) across the genome for association with phenotypic traits 
(210). Several GWAS have been included in a meta-analysis by Jones et al (211). The authors 
found SNPs at 9 loci near the genes PSRC1-CELSR2-SORT1, IL6R, CDKN2BAS1/ANRIL, 
DAB2IP, LDLR, SMYD2, LINC00540, PCIF1-ZNF335-MMP9 and ERG. With the 
exception of loci near PSRC1-CELSR2-SORT1, CDKN2BAS1/ANRIL and LDLR, these 
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seem to be specific for AAA. The identified SNPs were associated with transcription factor 
binding site affinity variations and eight of them had potential for long-range interactions, 
with two affecting expression of proximal genes in normal arterial tissue (expression 
quantitative trait loci, eQTL). Rarer single nucleotide variants have been quantified in 
patients with AAA and controls by use of whole-genome sequencing, compiled into a genetic 
risk score and used together with clinical characteristics to diagnose AAA (212).  
1.2.11 Transcriptomics 
 
The word transcriptome refers to the entirety of RNA molecules produced by a cell, tissue or 
organism (213). While the genome of an individual is identical throughout its body and 
lifetime, with important exceptions such as uncorrected DNA damage or specific 
rearrangements in for example lymphocytes, the pool of RNA produced by a cell, set of cells, 
tissue or organ at a certain time and given any type of stimulation is specific. The 
transcriptome is thus a snapshot; cropped in time and space. Researchers were long forced to 
study the expression of one gene at a time, which was time-consuming and laborious. 
However, the mid-90’s saw the advent of microarray technology, which for the first time 
could measure the (relative) expression of all known protein-coding and later non-coding 
genes at the same time. Further strides were taken with the introduction of RNA-sequencing, 
which enabled absolute quantification, de novo-sequencing and nucleotide-level differences 
between transcripts, as well as single cell RNA-sequencing which resolves these features to 
the transcriptome of single cells (214). Transcriptomics by microarray or RNAseq also allow 
querying which functional groups of genes, ‘gene sets’ or ‘pathways’, are enriched in a 
sample (215,216). As these technologies became and are becoming accessible, the use of 
transcriptomic approaches is now widespread (Figure 8). Features and limitations of 
microarray analyses are discussed in section 3.8 
 
As alluded to in previous sections, the common, degenerative AAA seems to be of a highly 
complex and multifactorial nature and finding a singular disease-causing gene, protein or cell 
type is an unlikely prospect. Instead, recent investigations into aneurysm disease involved 
genome-wide expression analyses by use of microarrays on both tissue and peripheral blood 
(Table 2). Microarray-based comparisons between full-thickness tissue from AAA and 
control aorta (the latter from autopsies or organ donation) have shown upregulations of 
pathways related to immune functions such as those related to NK-, T- and B-cells as well as 
complement cascade, cytokine and chemokine signaling, whereas downregulated genes 
Figure 8: PubMed search results for publications about transcriptomics and abdominal aortic 
aneurysm. A: search term: (microarray* OR transcriptom* OR "RNA sequencing" OR "RNA seq"). B: 
search term: “abdominal aortic aneurysm”. 
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included those related to muscle cells and lipid metabolism (113,217–219). These immune 
pathways seem to be upregulated even in the non-aneurysmal proximal neck just below the 
renal arteries (220). Other studies have focused on ruptured AAAs, comparing either paired 
samples from the same patient, ie non-ruptured with ruptured areas in the aneurysm, or 
comparing tissue from patients treated electively or for rupture. These analyses have pointed 
to an association between rupture and angiogenesis, immunity/inflammation and adipogenic 
degeneration (221–223). An intriguing pathophysiological observation was made when 
vSMCs from AAA, compared with those from carotid endarterectomies and nondilated aorta 
from organ donors, were shown to be transcriptionally distinct, overexpress MMP2 and -9 
mRNA and protein as well as having an increased elastolytic activity (224).  
 
Several studies have looked for non- or minimally invasive correlates with AAA biology, 
such as imaging and blood tests. The RNA from a blood sample of a patient with AAA differs 
significantly from that of healthy controls, with increased expression of genes related to 
apoptosis, immunity and proteolysis, but also differs from blood taken from patients with 
carotid artery stenosis (225,226). One study examined the association between global gene 
expression and a signal on positron emission tomography (PET) CT, whereas others have 
compared regions of high and low biomechanical wall stress or rupture risk (227–229). 
Finding non-invasive methods (or minimally invasive, such as a blood test) that can reveal 
active processes in the aneurysm vessel wall is an attractive approach to improving 
predictions of growth, risk of rupture or complications after EVAR. 
 
Table 2: Transcriptomic investigations of mRNA expression in humans with abdominal 
aortic aneurysm 
 
Publication, 
Authors 
Year, 
journal, 
data 
availability 
Platform(s) Experiment Key Results 
“Whole Genome-expression 
Profiling Reveals a Role for 
Immune and Inflammatory 
Response in Abdominal 
Aortic Aneurysm Rupture” 
 
Choke E et al. 
2006 
Ann N Y Acad 
Sci 
Affymetrix 
Human Genome 
U133A 
Paired, full-thickness 
tissue samples from 
aneurysm rupture edge 
and anterior vessel wall 
of 12 patients. 
Samples were pooled into 
triplicates. 
 
Dysregulation of genes 
related to immune and 
inflammatory responses 
“Global expression profiles 
in human normal and 
aneurysmal abdominal 
aorta based on two distinct 
whole genome microarray 
platforms.” 
 
Lenk et al. 
2006 
Ann N Y Acad 
Sci 
 
NCBI GEO: 
GSE7084 
Affymetrix 
Human Genome 
U133 Plus 2.0 
Array 
Illumina Sentrix 
Human-6 
Expression 
BeadChip 
Full-thickness tissue 
samples of from  
7 AAAs and 7 controls 
from autopsy. Matched 
for age, sex and ethnicity. 
Affymetrix: 4 pools. 
Illumina: 13 induvidual 
samples and 2 pools. 
Genes considered 
expressed in both 
platforms were analyzed. 
 
Overrepresentation of genes 
related to immunity and 
defense, cell communication 
as well as cell structure and 
motility 
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1) “Gene expression 
profiling of peripheral 
blood in patients with 
abdominal aortic 
aneurysm.” 
 
Giusti et al. 
 
2) “Carotid Artery Disease: 
Novel Pathophysiological 
Mechanisms Identified by 
Gene-expression Profiling 
of Peripheral Blood” 
 
Rossi et al. 
1) 2009 
Eur J Vasc 
Endovasc Surg 
 
2) 2010 
Eur J Vasc 
Endovasc Surg 
 
ArrayExpress: 
E-mexp-1346 
Human AROS 
v1.1, Operon 
Technologies 
Total RNA from venous 
blood 
1) 10 AAA patients, 10 
healthy controls 
Analyzed in four pools 
(2x5 AAA patients and 
2x5 healthy controls) 
 
2) 10 carotid artery 
stenosis (CAS) patients, 
10 healthy controls. 
Analyzed in four pools 
2x5 carotid patients and 
2x5 healthy controls. 
Results compared with 1). 
Two replicates with dye 
swap. 
 
1) Increased expression of 
hemoglobin changes and 
genes involved in erythrocyte 
stability. 
 
2) Dysregulation of immune 
response in CAS, lipid 
metabolic processes in AAA. 
“Smooth muscle cells from 
abdominal aortic 
aneurysms are unique and 
can independently and 
synergistically degrade 
insoluble elastin.” 
 
Airhart et al. 
2014 
J Vasc Surg 
Affymetrix HG-
U133 Plus 
GeneChip 
and 
Illumina Human 
HT-12 v4 
Expression 
BeadChip 
Microdissected vessel 
wall layers; intima, media 
and adventitia. 
vSMC from 22 AAAs, 29 
CAS and 17 nondilated 
abdominal aortas. 
vSMC lines pos for alpha 
smooth muscle actin, neg 
for CD11c, CD20, CD3, 
CD31 and CD68. 
 
vSMC from AAA have a 
unique transcriptome and 
they have an elastolytic 
phenotype which can be 
amplified by macrophages. 
“Differential gene 
expression in the proximal 
neck of human abdominal 
aortic aneurysm.” 
 
Biros et al. 
2014 
Atherosclerosis 
 
NCBI GEO: 
GSE47472 
Illumina 
HumanHT-12v4 
Expression 
BeadChip 
Full-thickness tissue 
samples from neck of 14 
AAAs and juxtarenal 
aorta of 8 organ donor 
controls, no significant 
difference in age and sex 
between AAA patients 
and controls. 
 
Upregulation of immune 
pathways in the non-
aneurysmal aorta proximal to 
the AAA. 
“Gene Expression Study in 
Positron Emission 
Tomography–Positive 
Abdominal Aortic 
Aneurysms Identifies 
CCL18 as a Potential 
Biomarker for Rupture 
Risk” 
 
Courtois et al. 
2014 
Mol Med 
Affymetrix 
U133Plus2.0 
chip 
12 AAA patients. 
6 AAAs patients with 18F-
FDG uptake, tissue 
samples from areas with 
and without uptake. 
6 AAA patients without 
18F-FDG uptake. 
Adventitia and Media 
were separated, Samples 
were pooled into groups. 
Genes related to matrix 
remodeling, inflammation 
and osteochondral 
development were 
differentially expressed in 
areas with 18F-FDG-uptake 
compared with areas without. 
“Differential gene 
expression in human 
abdominal aortic aneurysm 
and aortic occlusive 
disease.” 
 
Biros et al. 
2015 
Oncotarget 
 
NCBI GEO: 
GSE57691 
Illumina 
HumanHT-12v4 
Expression 
BeadChip 
Full-thickness tissue 
samples from: 
49 AAAs, 9 aortas with 
atherosclerotic occlusive 
disease and 10 organ-
donor controls, 
significantly more women 
in control group but 
similar ages. 
 
The transcriptomes of AAA 
and aotherosclerotic 
occlusive disease are uniqe 
and there is minimal overlap 
of dysregulated genes 
compared with organ donor 
controls 
“Microarray-based Gene 
Expression Profiling of 
Abdominal Aortic 
Aneurysm” 
 
Butt et al. 
 
2016 
Eur J Vasc 
Endovasc Surg 
Illumina Human 
HT-12 
BeadChips 
Blood. 
12 AAAs 
12 healthy age- and sex-
matched controls 
Genes related to proteolysis, 
inflammation and apoptosis 
are dysregulated in the 
peripheral blood of patients 
with AAA 
“Increased Expression of 
Lamin A/C Correlate with 
Regions of High Wall Stress 
in Abdominal Aortic 
Aneurysms” 
 
Malkawi et al. 
 
2015 
Aorta 
(Stamford) 
Illumina Human 
Ref-8 vs. 3.0 
Bead Chips 
Paired full-thickness 
tissue samples from 3 
AAAs.  
Samples from high- and 
low- wall stress regions 
of the aneurysm. 
Lamin A/C is increased in 
areas of high wall stress in 
AAA. 
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“Gene Expression Profiling 
in Abdominal Aortic 
Aneurysms After Finite 
Element Rupture Risk 
Assessment” 
 
Erhart et al. 
 
2017 
J Endovasc Ther 
Illumina 
HumanHT-12 v4 
Expression 
BeadChip 
Paired full-thickness 
tissue samples from 6 
AAAs. 
Samples from aneurysm 
regions with high and low 
rupture risk. 
Genes related to ECM were 
increased in areas with high 
biomechanical rupture risk. 
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The transcription of DNA to mRNA, the fate of transcribed mRNA and to which proteins the 
mRNA will be translated are regulated by transcription factors and epigenetic factors such as 
histone modification, DNA methylation, microRNA (miRNA, miR) and long non-coding 
RNA (lncRNA). These mechanisms are usually studied separately but modern systems 
biology will try to integrate them to make predictions, understanding disease biology and 
finding relevant drug targets. 
 
Histone modification refers to the acetylation or deacetylation of the nucleosomic histone 
core. Acetylation of the histone lysine neutralizes its positive change, decreases its binding 
to the negatively charged DNA, leading to a more open DNA structure and an increase in 
transcriptional activity. De-acetylation leads to the opposite. Both mechanisms have been 
suggested to be active in AAA and inhibition of histone deacetylases decreased experimental 
aneurysm formation in a mouse model (208). DNA methylation of CpG islands within gene 
promoters modulate several of the main disease processes implicated in AAA, which makes 
this epigenetic mechanism an interesting target for study (230). It has been shown that the 
DNA of regulatory T-cells are methylated to a higher degree and that these cells are less 
frequent and less suppressive in patients with AAA (231,232).  
 
Influencing the stability and translation of mRNA, miRNAs are short non-coding RNA 
sequences which, after post-transcriptional modifications, targets mRNA by continuous base-
pairing (233). Several miRNAs have been studied in animal aneurysm models and human 
AAA. miR-21 has been shown to regulate SMC differentiation and proliferation and, further, 
appears to be protective against aneurysm formation in murine AAA models (234). miR-29, 
on the other hand, may play a disease-promoting role in AAA as it targets the mRNA of 
matrix proteins such as collagens, fibrillin-1 and elastin. Blocking miR-29 leads to increased 
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expression of these matrix proteins, downregulation of MMP-2 and 9 as well as decreased 
aneurysm expansion in murine models. In human AAA tissue, however, miR-29 was reduced 
compared with normal aortas (233). miR-24 has been suggested as protective against AAA, 
since miR-24 overexpression and inhibition attenuated and augmented, respectively, 
aneurysm development in murine models. Moreover, the miR-24 target chitinase 3-like-1 
protein was increased in large compared with small AAAs (235). Other miRNA studied in 
conjunction with AAA includes miR-143/145, miR-181b, miR-195 as well as miR-205 and 
miR-712, which inhibit TIMP3, and miR-33, which acts proinflammatory in SMCs and 
macrophages. The latter three can be inhibited to treat experimental aneurysms in mice (236).  
There is still a paucity of investigations into the influence of lncRNA and alternative splicing 
of mRNA in AAA disease. The lncRNA H19 was recently shown to be increased in 
progressing AAAs and its inhibition prevented aneurysms in two different experimental 
mouse models (172). Its expression correlated positively with apoptosis and negatively with 
SMC proliferation and survival, with HIF1-alpha identified as a major target. Further, the 
HIF 1-alpha-antisense RNA 1 (HIF1a-ASI) is increased in thoracoabdominal aortic 
aneurysms and silencing it protected vSMC against apoptosis in vitro (237). Examples of 
other lncRNAs of potential interest to AAA disease are SENCR and SMILR, which regulate 
SMC behavior, lnc-HLTF which correlates with the diameter of the ascending aorta and 
linc00540, implicated in the GWAS meta-analysis mentioned above (236).  
1.3 BIOMECHANICAL ASPECTS 
1.3.1 Basic concepts of vascular biomechanics 
 
The aorta is continuously exposed to complex mechanical forces, from the pulsating 
intraluminal blood flow, perivascular tissue and inherent residual stresses, which can be 
estimated with increasing accuracy due to recent advances in computation. As summarized 
by Gasser and Bäck et al (238,239), mechanical load on solid materials can be quantified as 
stress, defined as force per area and measured in Pa, such that 1	𝑃𝑎 = 1	𝑁/𝑚!. Per definition, 
the direction of the force relative to the area determines if the stress is considered shear stress, 
force parallel to the area, or normal stress, force perpendicular to the area (Figure 9). Stress 
is a tensorial quantity and the von Mises stress allows the expression of a general multiaxial 
stress state by a single number. It is commonly used to determine when a ductile material 
will fail. The underlying rational will not be elaborated on in the present thesis.  
 
Stress applied to a material causes deformation, or strain, a unitless measurement of the 
relative change of angle or length for shear and normal strain, respectively (Figure 9). The 
degree to which tissue strains when exposed to stress is quantified as stiffness. Vascular tissue 
has non-linear stress-strain properties, where the stiffness increases with increasing strain. If 
the energy that is needed to deform a material can be fully recovered upon unloading, the 
material is elastic, sometimes also called hyperelastic. Given a viscoelastic material, the 
energy is not fully recovered after unloading but partly dissipated instead. Elastic and 
viscoelastic bodies return to their initial sizes and shapes after unloading (238,239). Elasticity 
(or viscoelasticity) remains up to a point when irreversible deformation occurs. The material 
then yields at its elastic limit, a point that determines its strength. Material failure, such as 
yielding or rupture, occurs when the stress of a material overcomes its strength, both 
quantified in Pa. Further, if the material properties are similar in all spatial orientations, the 
material is said to be isotropic, it is otherwise anisotropic. A material that preserves its 
volume during deformation is incompressible. In order to estimate the biomechanical 
behavior of a material, these and other mechanical properties should be described and 
formulated into a constitutive model. An important framework to create and use such models 
is continuum mechanics, which consider a macromaterial as a continuum of small 
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subvolumes, representative volume elements. If the material properties of one such 
subvolume is known, the macromaterial as a whole can be modeled. While many major 
structures are heterogenous, successful predictions can generally be made with this approach. 
1.3.2 Biomechanics of the normal aorta and abdominal aortic aneurysm 
 
The biomechanical characteristics of biological tissue can be ascertained by tensile testing 
whereby a tissue sample is strained with increasing force in a machine and the relationship 
between applied force and resulting stress and strain is mapped. The force can be applied in 
one (uniaxial) or two (biaxial) directions. The biomechanical testing results reported on 
below are from application of perpendicular force (resulting in normal stress). Some literature 
on shear stress is described but mechanical shear testing on tissue samples are not elaborated 
on since peak shear stresses measured in such experiments are at least an order of magnitude 
smaller than normal stresses (240) and, further, that the papers included in this thesis does 
not consider shear stress from flowing blood. Stress is usually estimated by dividing the 
applied force with the cross-sectional area of the tissue sample as it measured before the 
sample was stretched. 
 
The normal artery exhibits a viscoelastic, nonlinear stress-strain response. At low strain 
levels, elastin dominates with low stiffness but strong recoil. Collagen fibers in an unloaded 
artery have a wavy and relaxed appearance but as the artery is further strained, more and 
more collagen fibers are being stretched and contribute to the artery’s increasing stiffness, 
causing a nonlinear stiffening (Figure 10A) (81,241,242). Further, most collagen fibers are 
aligned circumferentially, explaining why arteries are typically stiffer in this direction and 
thus anisotropic (86). It has also been shown that the strain of the volume of the artery vessel 
wall is considerably smaller than the circumferential strain, why incompressibility may be 
assumed in biomechanical modeling (243). The presence in arteries of residual stress, defined 
Figure 9: Illustration of normal and shear stress and strain. Dashed line indicates initial 
configuration.  
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as the stress a solid material imparts on itself when external stressors are removed, is well-
known and apparent from the opening angle that occurs when an (externally unloaded) 
arterial ring is cut open (244).  
 
The aorta, specifically, is highly compliant and its distention and recoil during systole and 
diastole is crucial for the maintenance of continuous flow and pressure throughout the 
vascular tree. From the proximal ascending aorta to the distal infrarenal aorta, the stiffness 
gradually rises as the thicknesses of media and adventitia decreases and increases, 
respectively (245,246). There is also an elevated amount of collagen in the media of the 
abdominal aorta (246). These characteristics change with age and the aging aorta is 
characterized by elastic fiber fragmentation and collagenous remodeling (with increased 
stiffness and diameter as a result), as well as a decreased amount of vSMCs (247). 
 
The vessel wall of AAA is weaker compared with that of a normal abdominal aorta and most 
reports also show increased stiffness in AAA, with some exceptions (248), which seems to 
be most pronounced in the circumferential direction (81,240,248–250). Further, ruptured 
AAA had lower a wall strength compared with asymptomatic AAA in one study (251) 
(Figure 10B), whereas the pooled ruptured and symptomatic AAA had similar wall strength 
as asymptomatic AAA in a larger study (252). Efforts have been made to enable the 
estimation of wall strength in a patient without access to tissue, which is impossible to obtain 
without open surgery of the aneurysm. In a multivariable model, it was found that increased 
local diameter normalized to the expected normal diameter, increased ILT thickness, female 
sex and positive family history were significantly associated with a decreased wall strength 
(253). It has also been suggested that diabetes and increased plasma potassium makes the 
wall weaker (254), whereas vessel wall from AAA patients with chronic obstructive 
pulmonary disease appears to be stronger than AAA patients without this disease (255) 
Counterintuitively, wall strength appears to correlate negatively with wall thickness (254). 
Wall strength (which is the maximal wall stress reached before tissue rupture) is 
mathematically coupled to wall thickness, as wall stress depends on the cross-sectional area 
of a specimen. This means that for the same applied force, a lower stress is recorded in thicker 
walls. Wall thickness can be increased by potentially weakening inflammation and edema, 
which is supported by significant correlation between wall thickness and metabolic activity 
as measured by PET CT (254). On the other hand, failure tension, which is defined as the 
maximal applied force before rupture divided by the specimen width and is thus independent 
Figure 10: Schematic of uniaxial biomechanics of ex-vivo tissue from aorta and abdominal aortic 
aneurysm. A: Stress-strain curves from elastic loading of tissue from AAA and normal aorta. B: Stress-
strain curves for destructive loading of tissue from elective and ruptured AAA. 
Arrowheads denote point where yield (ie irreversible changes in tissue characteristics) occurs, cross 
denote rupture of tissue.  
Abbreviation; AAA: abdominal aortic aneurysm.   
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of the specimen (wall) thickness, correlates positively with wall thickness (254). These 
findings complicate the use of wall thickness in biomechanical models. Finally, most but not 
all, of these investigations have relied on uniaxial tensile testing which is why most models 
are based on uniaxially derived data whereas anisotropy has been described in biaxial testing 
(240,256) 
 
Early clinical indications of an interaction between hemodynamics and AAA came in the late 
1980’s when it was observed that an unexpectedly high proportion of all AAA ruptures 
occurred in patients who had suffered World War II-related leg amputations (257). A 
prospective study later revealed that above-the-knee amputees, compared with controls, up 
to 40 years later had a significantly higher prevalence of AAA and that the aortas of the 
amputees were axially shifted towards the remaining leg’s iliac artery, implicating 
hemodynamic perturbation as a culprit in AAA disease (258). Further clinical support to this 
notion came from observations that spinal cord injury is associated with an increased 
infrarenal aortic diameter (259) and that PAD is an independent risk factor for AAA (108), 
both conditions causing altered outflow from the aorta. Resistance to aortic outflow has been 
shown to decrease antegrade and oscillatory wall shear stress in the infrarenal aorta (259). In 
line with these findings, it has been observed that patients with AAA and occlusion in one or 
more iliac artery, as well as those with PAD, and thus have an obstructed outflow from the 
infrarenal aorta, rupture at significantly smaller diameters compared with those without 
(260).  
 
Shear stress is lower in the distal compared to the proximal aorta and preclinical 
investigations have revealed an anti-inflammatory phenotype in cells exposed to high shear 
stress (261), which implies susceptibility of the infrarenal aorta to hemodynamics-
substantiated inflammation. The vSMCs senses alterations in hemodynamic forces from 
endothelial cell signaling and interactions with the vascular extracellular matrix, to which 
this cell population responds with phenotypic modulation and matrix remodeling (262). 
Moreover, native murine aorta expresses higher levels of MMP-9 in its abdominal, compared 
with its thoracic, segment but this association is reversed when the thoracic aorta is 
transplanted into the infrarenal segment (263). Increased hemodynamic load have further 
been demonstrated to cause disruption of elastic laminae, possibly mediated by MMP-2 and 
-9 and it has also been demonstrated that endogenous nitric oxide and reactive oxygen species 
modulate expression and activity of MMPs in response to altered flow (264,265). In mice of 
normal aortas and elastase-induced aneurysms, computationally estimated shear stress 
strongly associated with aortic gene expression and mechanically altered flow markedly 
affected the aneurysm size, degree of apoptosis and inflammation (266,267). Results from 
our group also suggest a wall stress-independent association between local diameter growth 
rate and wall shear stress in AAA (268). However, while flow patterns may contribute to 
aneurysm formation, it is not clear to what extent they influence the rupture risk of manifest 
AAA. Areas of aneurysm rupture typically display high normal stress but the shear stress is 
orders of magnitude lower (269,270). The luminal aspect of the aneurysm vessel wall is also 
covered by an ILT, which shields it from the frictional force of flowing blood, and the AAA 
is also lacking endothelium, possibly prohibiting a large share of the shear-stress induced 
vessel wall signaling (5,238,269,270). For these reasons, rupture of the AAA vessel wall 
seems to primarily be caused by normal, rather than shear, stress. This motivates the analysis 
of wall stress and wall strength under blood pressure without including highly complex 
simulations of blood flow (63,253,270–277). 
 
A number of studies have described molecular responses to normal stress of the vessel wall. 
In investigations on coronary artery stenosis, computationally estimated stress of the 
atherosclerotic plaque has been shown to correlate with expression of MMP-1 and important 
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A number of studies have described molecular responses to normal stress of the vessel wall. 
In investigations on coronary artery stenosis, computationally estimated stress of the 
atherosclerotic plaque has been shown to correlate with expression of MMP-1 and important 
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inflammatory mediators (278,279). Thoracic aortic aneurysms show signs of vSMC 
phenotypic modulation into a synthetic phenotype at areas of high wall stress (280). An 
intriguing concept of biomechanical-biological interactions in AAA was that of segmental 
aortic stiffening increasing the axial tensile stress in adjacent, compliant, segments causing 
increased inflammation and proteolysis, which also correlated with age-related changes in 
the human aorta (281). Investigations into associations between gene expression and wall 
stress or the estimated ratio between wall stress and wall strength have pointed to differences 
in expression of lamin A/C and genes related to ECM and cytokine signaling, while strong 
associations surviving correction for multiple testing are difficult to obtain (228,229,282). 
On the protein/structural/cellular level, high ratio between wall stress and wall strength was 
associated with decreased vSMCs and elastic fibers as well as more cholesterol and calcified 
plaques, whereas increased wall stress was associated with increased collagen 1, III and total 
collagen (283). With respect to local tissue mechanics, stiffness and strength of the AAA 
vessel wall correlate negatively with MMP2 gene expression (282). Finally, mechanical 
stretching of vSMCs cause oxidative stress and makes them pro-inflammatory, -fibrotic and 
-proteolytic (284–286). 
 
1.3.3 Molecular biology and biomechanics of the intraluminal thrombus 
 
The interaction between biology and biomechanics has become apparent in investigations 
into the role of the ILT. This mesh of fibrin, red blood cells, leukocytes and enzymes was 
initially disregarded as inert but has through experimental and computational efforts been 
shown to play dualistic roles in the AAA. The thrombus is preferentially located in the distal 
half of the aneurysm and its formation is likely related to an environment of vortical flow, 
recirculation and exposure of the subendothelium (287). Mechanically, the ILT is isotropic, 
exhibits a mildly non-linear stress-strain curve and is sensitive to mechanical fatigue under 
pulsatile load (288,289). The formed thrombus appears to act as a cushion, protecting the 
wall against stress, and is important to include in the biomechanical modeling in order to get 
accurate rupture predictions (273,290). However, it has been observed that the ILT-covered 
AAA wall, compared with the ILT-free wall, displays sings of hypoxia, elastin fragmentation, 
vSMC apoptosis, proteolysis and, consequently, decreased wall strength (171,291,292). 
Potential explanations have been found in the ILT, which contain high concentrations of 
neutrophils, capable of releasing gelatinases and serine proteases. Further, the ILT adjacent 
to the vessel wall display active membrane-bound proteases and high activity of fibrinolysis 
by plasmin, the latter also able to activate MMPs and degrade fibrinogen (98,140). The ILT 
has also been shown to contain neutrophils expressing elastase, antitrypsin and MMP9 among 
others, preferentially in its luminal layer (293). Neutrophils may also increase their elastase 
activity in the presence of nicotine (294).  
 
In summary then, while it cushions and protects the aneurysm wall against stress, the ILT 
simultaneously contributes to its destruction. Thus it appears likely that failure of the ILT 
would be detrimental to the aneurysm, causing increased stress in a weakened vessel wall 
(295). Clinical data support this hypothesis as radiological signs of ILT crack propagation 
and failure, such as crescent-like (296), diffuse (297) and localized (298) hyperattenuations 
in the ILT, are described as risk factors for frank aneurysm rupture.  
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1.4 LIMITATIONS OF PRESENT-DAY MANAGEMENT  
 
The current management of AAA requires repeated and frequent diameter measurements 
when the aneurysm is small, as the growth rate of a specific aneurysm is difficult to predict 
(2,3,59). When the aneurysm reaches 50 mm in women and 55 mm in men, the patient is 
evaluated for EVAR or OAR, both of which are resource-demanding and associated with 
significant morbidity and mortality (299). The level of infrastructure, logistics and costs 
required to adequately follow present guidelines may prohibit treatment for many with a 
diagnosed or yet undiagnosed AAA (69,70). Further, even in a high-resource setting, some 
patients with small AAA will suffer from rupture despite being enrolled into surveillance 
(19,21,61,62). Enhanced precision of surveillance, such as predictions of growth or future 
need for surgery, would greatly improve management of AAA patients. Establishing an 
effective biomarker could make AAA diagnosis more accessible and the development of a 
pharmaceutical treatment would save numerous lives worldwide. 
 
1.5 SUGGESTED METHODS TO MEASURE AND PREDICT GROWTH AND 
RUPTURE OF ABDOMINAL AORTIC ANEURYSMS 
 
The maximal external diameter of the AAA has been used as the gold standard to predict 
aneurysm growth and rupture. Current guidelines on timing of surgery and surveillance 
intervals rely on diameter measurements by US or CT (2,3). As a predictor of rupture, the 
diameter works well on a population level but is imprecise in the individual perspective with 
a small but existing share of patients with small AAAs suffering from rupture, while a large 
proportion of patients with large AAAs does not (18,19,61,63). Further, the correlation 
between baseline diameter and its future growth rate is weak, necessitating frequent 
measurements (58,300). Other weakness include variations in technique, with respect to 
which US “edges” to measure between and in which plane to perform the measurement as 
well as the inherent weakness of following the evolution of a 3D object with a 2D metric, 
which can miss rapid changes outside the maximal diameter plane (301,302).  
 
Several geometric indices and tracer imaging methods have been proposed to improve the 
prediction of AAA outcome. The volume of the AAA is commonly measured between the 
renal arteries and the aortic bifurcation and encompasses both the effective lumen and the 
ILT. It is a more sensitive measurement of growth than diameter, with a large share of AAAs 
expanding in volume despite being stable in diameter (303,304). Our group has also observed 
that volume growth of AAA is easier to predict and better corresponds with biomechanical 
deterioration compared with diameter growth (305). The size and structure of the ILT have 
been connected to both rupture and growth. For example, thicker ILT, asymmetric and 
anterior position of the ILT, the share of the aneurysm wall arc covered by thrombus and the 
relative ILT cross-sectional area have all been proposed as predictors of AAA growth 
(290,300,306–308), whereas the growth rate of the thrombus itself, localized and crescent-
shaped hyperattenuations as well as the general attenuation of the thrombus have been 
associated with rupture (296–298,309). Fluorodeoxyglucose (18F-FDG) is a PET tracer used 
to detect tissue metabolism and its uptake in the AAA vessel wall has been associated with 
increased risk of symptomatic AAA and pathological molecular remodeling (310,311) but 
seems on the other hand to correlate negatively with aneurysm growth rate, with suggested 
cyclical changes in uptake which could complicate the interpretation of these measurement 
(312,313). Prospective studies have been performed that evaluated ultrasmall 
superparamagnetic particles of iron oxide (USPIO) on MRI, corresponding with macrophage 
presence and cellular inflammation, and 18F–sodium fluoride (18F-NaF) on PET-CT, which 
can identify early microcalcification (314,315). The signals from both tracers were associated 
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with an increased growth rate and rate of repair or rupture, independently of baseline diameter 
in the case of 18F-NaF but not USPIO.  
 
Many circulating biomarkers have been evaluated and have mainly been related to 
inflammation, ECM turnover, coagulation and lipids (316). Specifically, molecules related 
to inflammation shown to be associated with AAA growth rate in single studies include IFNγ, 
neutrophil gelatinase-associated lipocalin, osteopontin and soluble tumor necrosis factor-like 
weak inducer of apoptosis, with varying results on C-reactive protein and tumor necrosis 
factor alpha (316–320). Motived by common presence of an ILT in clinically relevant AAA, 
several hemostasis-related molecules have been proposed as markers of AAA presence, size 
and growth (316,321). D-dimer is one of the most studied markers and is increased in patients 
with AAA and correlates with aneurysm size and growth rates (321,322). Other markers 
include fibrinogen which is increased in patients with AAA, plasmin-antiplasmin complexes 
which correlates with growth rate and thrombin-antithrombin III-complexes which are 
increased in AAA and show varying results with respect to size (321). Serum triglycerides 
seem to be associated with risk of AAA rupture, elastin peptides with AAA growth rate and 
type XVIII collagen with aneurysm presence and growth rate, although the latter association 
was not independent of baseline diameter (126,323,324). The levels of several miRNAs are 
altered in AAA (325). 
 
FEA is a numerical method commonly used to solve complex engineering problems by 
subdivision of a system into smaller, simpler parts (‘finite elements’). These elements can 
then be reassembled into a whole, providing a simpler estimation of the solution. This method 
and its application in AAA prediction are further explained in section 3.3. The underlying 
principle behind predicting rupture of AAA by FEA is that the vessel wall fails when its 
stress overcomes its strength. Studies to estimate wall stress by FEA in AAA were performed 
as early as the late 80’s and 90’s but started to increase in the early 2000’s (274,326,327). 
After initial mapping and modeling of the biomechanical characteristics of the AAA vessel 
wall (249,328,329), the first 
successful implementation of FEA to 
predict emergency surgery of AAA 
was performed by Fillinger MF et al in 
2003 where peak wall stress (PWS) 
was found to be superior to the 
maximal diameter (271). A number of 
similar papers were subsequently 
published and a meta-analysis from 
2014 concluded that PWS is higher in 
symptomatic or ruptured AAA 
compared with asymptomatic and 
intact AAAs (274). In order to further 
improve rupture predictions, 
estimations of wall strength have been 
incorporated into the FEA based on ex 
vivo tensile testing 
(253,270,272,273,275,276,330–334). 
Specifically, the highest estimated 
ratio between wall stress and wall 
strength (referred to in this thesis as 
peak wall rupture risk index – PWRI, 
Figure 11) is used as a predictor of 
rupture and can be converted into a 
Figure 11: 3D-modeling and finite element analysis to 
measure volumes and estimate peak wall rupture 
index. As performed by A4clinics  Research Edition 
(Vascops GmbH). 
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rupture risk equivalent diameter (RRED) based on diameter-PWRI associations in large 
studies (334). This approach has been implemented with different software, of which two are 
widely accessible; the commercial A4clinics (Vascops GmbH) and the partially free/open 
source software system BioPARR (273,333). Further developments include a probabilistic 
rupture risk index, developed to account for uncertainties of the modeling (331). Five studies, 
of which four compared aneurysms of matching diameters, investigated AAAs that had 
already ruptured with those that had not, and in three of them it was shown that PWRI was 
increased in ruptured AAA, whereas there was no difference in the other two 
(63,273,275,332,335). PWRI was also found to be increased in only symptomatic as well as 
pooled ruptured and symptomatic AAAs compared with diameter-matched asymptomatic 
AAAs (272,332). In further support of the value of wall stress/wall strength-ratios as rupture 
predictors, two studies have been published that compare FEA-derived PWRI from images 
of asymptomatic AAAs that ruptured after the CT image was taken with asymptomatic AAAs 
that remained intact, both showing an increased PWRI in aneurysms that would later rupture 
(270,330). A recent prospective study also demonstrated the potential of the wall stress/wall-
strength ratio to predict a composite of rupture or elective aneurysm repair independently of 
diameter (276). Finally, the utilization of machine learning in medical diagnostics is a rapidly 
evolving field which is starting to encompass AAA research as well. Examples include the 
use of several anatomical variables in an extreme gradient boosting-algorithm to predict rapid 
diameter growth rate (336) and Bayesian modeling of AAA growth patterns (337). 
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2 AIMS 
 
The overall aim of this thesis was to explore and develop new strategies to improve, refine 
and individualize management of patients with AAA by applying geometric, biomechanical 
and molecular analyses. Specifically, we aimed to evaluate how clinical rupture risk factors 
are linked to AAA biomechanics, improve the prediction of AAA progression, find potential 
circulating biomarkers of AAA as well as to comprehensively map how gene expression is 
altered in AAA compared with normal aorta, considering smoking and the AAA progression 
rate. 
 
I. Gender, Smoking, Body Size, and Aneurysm Geometry Influence the 
Biomechanical Rupture Risk of Abdominal Aortic Aneurysms as Estimated 
by Finite Element Analysis. 
 
- To investigate if established clinical risk factors for rupture are associated with 
biomechanical stress and rupture risk in order to gain biomechanical insight into 
what has been observed in epidemiological studies, as well as to assess the ability 
of FEA to consider clinically important patient characteristics. 
 
II. Geometric and Biomechanical Prediction Modeling of Growth, Treatment 
and Outcome of Small Abdominal Aortic Aneurysms Using Machine 
Learning. 
 
- To determine whether additional geometric or biomechanical indices in small 
AAAs could improve predictions of which patients would reach the threshold for 
surgery within four years, their future growth rate and the occurrence of rupture 
or symptomatic AAA.  
 
III. Neutrophil Elastase-Derived Fibrin Degradation Products Indicate Presence 
of Abdominal Aortic Aneurysms and Correlate with Intraluminal Thrombus 
Volume. 
 
- To study E-XDP as a marker of neutrophil-induced degradation of the aneurysm-
related ILT as well as to evaluate to what extent this marker is associated the ILT 
and aneurysm volume, diameter and biomechanical rupture risk.  
 
IV. Tunica-Specific Transcriptome of Abdominal Aortic Aneurysm and the Effect 
of Intraluminal Thrombus, Smoking and Diameter Growth Rate. 
 
- To detect novel pathophysiologic features of AAA by tunica-specific microarray 
analysis of the genome-wide expression of genes in ILT-free and -covered aspects 
of the human AAA wall.  
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3 MATERIAL AND METHODS 
 
The geometry and biomechanics of AAA were investigated by means of 3D segmentation 
and FEA based on CT images. Fibrin degradation products in peripheral blood were 
quantified by enzyme-linked immunosorbent assay (ELISA) and latex-enhanced 
turbidimetry. Aortic wall biopsies were analyzed with immunohistochemistry and 
microarrays. Patient data was collected from electronic medical records and information 
about organ donors was collected from pre-filled forms. Included patients may overlap 
between the different studies. An overview of methods is shown in Table 3. 
 
Table 3: Overview of study methods. 
Study Study subjects Design Principal methods 
I. Patients w AAA 
of 40 - 60 mm 
diameter. 
n = 146 
Analysis of one CTA per patient. Simple 
and multiple regression to test associations 
between biomechanical rupture risk, 
geometry and clinical risk factors. FEA 
was conducted both uninformed ‘neutral’ 
and informed ‘specific’ of patient 
characteristics. 
 
3D segmentation and FEA. 
Simple and multiple linear regression. 
II. Patients w AAA 
of 40 - 50 mm 
diameter. 
n = 191 
Analysis of one or two CTAs per patient. 
The precision of multivariable models to 
predict future indication for surgery, 
growth rate of diameter and volume as well 
as rupture or symptomatic aneurysm was 
evaluated. 
3D segmentation and FEA. 
Simple and multiple linear regression, 
ridge regression, LASSO and SVM 
prediction modeling with 10-fold CV. 
Accuracy tested with ROC, Pearson’s 
and Spearman’s rank correlation 
coefficients. 
 
III.  Patients w AAA 
of 45-80 mm 
diameter,  
n = 37 + 51. 
Controls from 
screening,  
n = 42, and from 
organ donation. 
 
E-XDP and D-dimer were measured in 
plasma from patients and controls.  
Analysis of one CTA per patient. 
Microscopy of AAA tissue from OAR and 
and juxtarenal control aorta from organ 
donors 
3D segmentation and FEA. 
ELISA, latex-enhanced turbidimetry. 
Immunohistochemistry. 
IV. Patients w AAA, 
n = 76. 
Controls from 
organ donation, 
n = 13. 
Tissue samples from thrombus-free and 
thrombus-covered AAA and juxtarenal 
control aorta were dissected into media 
and adventitia. 
RNA was purified and analyzed by 
microarrays. 
Normalized gene expression data were 
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3 MATERIAL AND METHODS 
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3.1 STUDY SUBJECTS  
 
Three categories of study subjects are included in this thesis; patients with AAA, control 
subjects without AAA recruited from screening and organ donors. Patients with AAA were 
all managed at and included from the Department of Vascular Surgery at the Karolinska 
University Hospital. Patient data were collected from electronic medical records, CT images 
were anonymized and downloaded, blood samples were collected preoperatively and tissue 
samples were collected during elective open AAA surgery from the anterior vessel wall at 
the approximate level of the maximal aneurysm diameter. Men of 65 years’ age invited for 
screening in Stockholm and not found to have AAA on US were included as controls. After 
consent, a health questionnaire was answered and blood samples were obtained. Tissue of 
normal-diameter aorta was collected from juxta-renal aorta during organ harvesting from 
brain-dead, beating heart organ donors. The patients of study I and II were included 
retrospectively and did not give informed consent, whereas study III and IV included patients 
and controls after informed consent had been given. All studies were approved by the local 
ethics review board and performed according to the declaration of Helsinki. An elaboration 
on ethical considerations is given in section 3.12.  
 
General exclusion criteria were AAAs resulting from known congenital connective tissue 
disorders, infections or acute autoimmune conditions as well as rupture, abdominal aortic 
surgery or symptomatic AAA before or at the time of the baseline CT or sampling. In order 
to perform FEA, the geometries of ILT and lumen are required, necessitating a CTA. Patients 
who were unable to undergo such imaging, due to pronounced renal failure for example, were 
excluded from this type of analysis.  
3.2 STAAAB – STOCKHOLM ABDOMINAL AORTIC ANEURYSM BIOBANK 
 
The Department of Vascular Surgery and the Vascular Surgery research group at the 
Karolinska University Hospital and Karolinska Institutet, respectively, have over the last 
decade assembled a biobank of tissue and blood samples from patients with AAA and 
controls without AAA, the Stockholm AAA Biobank (StAAAB, Figure 12). The StAAAB 
presently comprises blood samples, patient data and CT images from over 600 patients with 
AAA, tissue of the vessel wall and ILT from over 150 of these patients, control blood samples 
from over 200 individuals attending AAA screening and control tissue from the abdominal 
aorta of around 30 organ donors. The recruitment and collection are ongoing and the biobank 
is continually expanding.  
 
The material is treated according to the following protocols. Plasma samples are anti-
coagulated with citrate or ethylenediaminetetraacetic acid and are centrifuged twice in order 
to obtain platelet-free plasma. Tissue samples are divided into three parts; for analysis of 
RNA, protein quantification and immunohistochemistry. Tissue samples for RNA are 
immersed in RNAlater (Thermo Fisher Scientific, Waltham, MA, USA) immediately after 
extraction, stored in 4° C for 48h, dissected into (intima)/media and adventitia layers and 
subsequently transferred to long term storage in -80° C. Samples for protein analysis are 
immediately placed on dry ice and moved to long term storage in -80° C. Biopsies intended 
for immunohistochemistry are immersed in 4% zinc formaldehyde, transferred to 70% 
ethanol after 2 days and finally paraffin embedded within approximately 2 weeks.  
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3.3 COMPUTED TOMOGRAPHY, GEOMETRIC MEASUREMENTS AND FINITE 
ELEMENT ANALYSIS 
 
Geometric and biomechanical analyses of CTAs were conducted by use of the commercial 
software A4clinics Research Edition produced by VASCOPS GmbH (Graz, Austria), which 
co-supervisor T. Christian Gasser has developed. Thorough descriptions of core 
functionality, important assumptions, optimization and clinical validation of this software 
can be found elsewhere (273,334,338). In short, this software performed 3D segmentation 
and FEA from CTA images in a semi-automatic, step-wise manner (Figure 13). In a first step, 
the contrast-enhanced lumen was automatically identified. The lumen geometry then served 
as the starting point for the software to find the vessel wall of the aneurysm. While this 
process was automatic, the investigator typically needed to correct the software to ensure 
Figure 12: Current state of the StAAAB - Stockholm Abdominal Aortic Aneurysm Biobank 
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precise identification of the vessel wall. When the lumen and wall model were constructed, 
space between lumen and the vessel wall was assumed to be ILT and wall thickness was 
estimated based on the presence of an overlying ILT (291). The finished model was then 
meshed. The AAA vessel wall was modeled as hyperelastic, incompressible and isotropic. 
The wall strength was modeled after previous ex vivo testing by which female sex and 
positive family history decreased wall strength globally, whereas the thickness of an 
overlying ILT and a large local diameter relative to the expected normal diameter decreased 
wall strength locally (253). The strength of the ILT decreased from the luminal to abluminal 
layer by 33% and the wall and ILT strengths were further lowered by 50% and 60%, 
respectively, to account for fatigue mechanisms induced by pulsatile loading (289). The 
model was subsequently loaded with patient-specific mean arterial pressure (MAP).  
 
 
All measurements and FEA were performed between the lowest main renal artery and the 
aortic bifurcation. The output variables were: semiautomatic diameter, which was 
automatically measured perpendicularly to the aneurysm centerline, aneurysm volume, 
maximal luminal diameter, lumen volume, maximal ILT thickness, ILT volume, mean ILT 
stress, mean wall stress (mean WS), PWS and PWRI. Indices PWS and PWRI represented the 
maximal wall stress and maximal ratio between wall stress and wall strength in the aneurysm, 
respectively. Mean WS was the average stress estimated in the aneurysm whereas mean ILT 
stress was the average stress of the ILT. The biomechanical rupture risk index can be 
converted to an RRED, based on average relationships between PWRI and aneurysm 
diameters, in order to improve interpretability (334).  
 
 
 
Figure 13: Finite element analysis by A4clinics Research Edition.  
Abbreviation; ILT: intraluminal thrombus 
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3.4 GROWTH RATES 
 
Patients with AAA are monitored by US rather than CTA in most centers world wide, which 
results in irregular intervals between CTA examinations in retrospective material. Thus, 
growth rates need to be calculated in a manner that corrects for differing time intervals 
between patients. Further, with exponential growth patterns suggested for AAA diameter and 
especially with 3D quantities (339,340), this correction needs to be nonlinear. Martufi G et 
al proposed a nonlinear growth model in 2013 which was employed in the current thesis 
(302). This model was used to calculate absolute and relative growth according to : 
 𝐴𝑏𝑠𝑜𝑙𝑢𝑡𝑒	𝑔𝑟𝑜𝑤𝑡ℎ	𝑟𝑎𝑡𝑒 = (𝐸𝑥𝑝(12𝑟) − 1) ∗ 𝑀!"#$%&'$	𝑚𝑚	𝑜𝑟	𝑐𝑚3𝑦𝑒𝑎𝑟 	
and 𝑅𝑒𝑙𝑎𝑡𝑖𝑣𝑒	𝑔𝑟𝑜𝑤𝑡ℎ	𝑟𝑎𝑡𝑒 = (𝐸𝑥𝑝(12𝑟) − 1) ∗ 100	 %𝑦𝑒𝑎𝑟 
 
with the logarithmic growth factor: 
 𝑟 = 1𝑡 ∗ 𝐿𝑛	(𝑀)*%%*+,-	𝑀!"#$%&'$ ) 
 
Where M is a measurement of either diameter or volume, t denotes the time between the 
patient’s baseline and follow-up CTA, Exp(•) and Ln(•) are the exponential and natural 
logarithmic functions of (•), respectively. This growth rate correlated to a high degree with a 
linear growth rate (ie the difference between follow-up and baseline measurement divided by 
the interval time) with decreasing but still high similarity with longer intervals.  
3.5 PREDICTION MODELING  
 
Statistical learning can be used to draw conclusions about to what degree input variables 
explain an outcome or to simply create a model that predicts the outcome without giving 
much consideration of causal interpretations. This process can be either supervised or 
unsupervised and predictions can either be probabilities of class membership, classification, 
or a continuous value, regression. While supervised learning is performed to create a model 
to predict an outcome, unsupervised learning works without an outcome measure and aims 
to structure or cluster data. A fundamental concern when training a prediction model is its 
external validity. It is easy to design an ‘overfitted’ model, especially in the presence of many 
predictor variables, if one tests the model on the same data it is trained on. In this case, it fits 
the data in a way that does not correspond to an underlying real structure but may instead be 
based on noise. Meanwhile, ineffective learning causes ‘underfitting’, in which real data 
structures are not captured by the model. Given this problem, a model needs to be carefully 
trained and then validated on data it has not been trained on. A convenient way to estimate 
how a modeling approach performs on external data is to divide a data set into training and 
test data, or to do this iteratively so that predictions can be made for all included subjects 
based on models trained on data that did not include them. The latter procedure is called 
‘cross-validation’ and is commonly used to estimate test error in order to create robust 
prediction models. Further, some models have ‘hyperparameters’ which are model 
parameters set before the model training process begins. These can be optimized with respect 
to prediction performance by use of for example additional cross-validation, referred to as 
‘tuning’. Preferably, the optimal modeling approach should then be trained on the entire 
dataset and subsequently be validated in external data. An example of this process, as 
undertaken in paper II and in one analysis of paper IV, is illustrated in Figure 14. Thorough 
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discussions of above considerations and the models included below are given elsewhere 
(341–343).  
 
Methods used in this thesis include simple and multiple linear and logistic regression, ridge 
regression, least absolute shrinkage and selection operator (LASSO), support vector machine 
(SVM), orthogonal projection to latent structures discrimination analysis (OPLS-DA) and t-
distributed stochastic neighbor embedding (t-SNE). Linear regression is an approach to 
model linear relationships between a continuous dependent and one or several independent 
variables, usually fitted by use of least squares, where the sum of squares, ie the squared 
differences between the observed value and the model’s fitted value, is minimized. Logistic 
regression models a binary dependent variable, outputting the probability of a subject 
belonging to a certain class by use of a logistic function. Ridge regression additionally 
imposes a penalty function, shrinks the regression coefficients and minimizes the penalized 
residual sum of squares. In LASSO, this penalty function can shrink some coefficients to 
zero, effectively performing feature selection. The SVM identifies a hyperplane with 
maximal margins between two classes, and can be performed with a linear approach or a by 
use of a non-linear kernel which is a way to achieve the effect of transforming data to a higher 
dimension feature space without the need to calculate the transformation of all vectors but 
rather the products between them. Ridge regression, LASSO and SVMs can be used in both 
classification and regression problems. Partial least squares or projection to latent structures 
is a method to project Y and X data to a new space, finding a multidimensional direction in 
the X space that explains maximal variance direction in the Y space. In OPLS-DA, systemic 
variation in X that does not correlate with/is orthogonal to Y is removed, which improves 
interpretability. Finally, while all previously mentioned methods were supervised, t-SNE is 
an unsupervised clustering and visualization technique for nonlinear dimensionality 
reduction in which each datapoint is given a location in a 2- or 3D map.  
 
52 
discussions of above considerations and the models included below are given elsewhere 
(341–343).  
 
Methods used in this thesis include simple and multiple linear and logistic regression, ridge 
regression, least absolute shrinkage and selection operator (LASSO), support vector machine 
(SVM), orthogonal projection to latent structures discrimination analysis (OPLS-DA) and t-
distributed stochastic neighbor embedding (t-SNE). Linear regression is an approach to 
model linear relationships between a continuous dependent and one or several independent 
variables, usually fitted by use of least squares, where the sum of squares, ie the squared 
differences between the observed value and the model’s fitted value, is minimized. Logistic 
regression models a binary dependent variable, outputting the probability of a subject 
belonging to a certain class by use of a logistic function. Ridge regression additionally 
imposes a penalty function, shrinks the regression coefficients and minimizes the penalized 
residual sum of squares. In LASSO, this penalty function can shrink some coefficients to 
zero, effectively performing feature selection. The SVM identifies a hyperplane with 
maximal margins between two classes, and can be performed with a linear approach or a by 
use of a non-linear kernel which is a way to achieve the effect of transforming data to a higher 
dimension feature space without the need to calculate the transformation of all vectors but 
rather the products between them. Ridge regression, LASSO and SVMs can be used in both 
classification and regression problems. Partial least squares or projection to latent structures 
is a method to project Y and X data to a new space, finding a multidimensional direction in 
the X space that explains maximal variance direction in the Y space. In OPLS-DA, systemic 
variation in X that does not correlate with/is orthogonal to Y is removed, which improves 
interpretability. Finally, while all previously mentioned methods were supervised, t-SNE is 
an unsupervised clustering and visualization technique for nonlinear dimensionality 
reduction in which each datapoint is given a location in a 2- or 3D map.  
54
  53 
 
3.6 E-XDP, ENZYME-LINKED IMMUNOSORBENT ASSAY AND TURBIDIMETRY 
 
Different epitopes are revealed on fibrin degradation products depending on which enzyme 
is involved. The commonly used fibrin degradation product D-dimer results from degradation 
of fibrin by plasmin. Neutrophil elastase is also able to digest fibrin. An antibody has been 
developed that recognizes an epitope specifically unmasked on fibrin fragments produced by 
neutrophil elastase, and importantly not on those produced by plasmin, cathepsin G, trypsin- 
or chymotrypsin-type enzymes (344). This antibody, IF-123, was used as capture antibody 
to detect neutrophil elastase-derived degradation products of fibrin/cross-linked fibrinogen 
(E-XDP) in study III. ELISA is a method used to detect and quantitate a molecule, typically 
a protein, in a sample by use of antibodies directed against this molecule (345). In-house 
sandwich ELISA was used in study III and proceeded by having the capture antibody attached 
to a solid surface to which the liquid sample was added. The protein of interest subsequently 
attached to the capture antibody, all non-bound protein was washed away and a secondary 
antibody was added, causing the antigen to be sandwiched between two antibodies. The 
secondary antibody was conjugated with horseradish peroxidase which reacted with substrate 
3,3′,5,5′-tetramethylbenzidine. The resulting color was quantified and the relationship 
between color and relative concentration of the protein was calibrated by use of a reference 
sample. In a validation experiment, fibrinogen was incubated with elastase, plasmin or 
reaction buffer alone during which samples were taken at 10-minute intervals and were 
analyzed with described ELISA.  
 
Figure 14: Method used in paper II to cross-validate (CV) predictions. In models that did not (A) and 
did (B) require parameter tuning.  
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Figure 14: Method used in paper II to cross-validate (CV) predictions. In models that did not (A) and 
did (B) require parameter tuning.  
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Levels of D-dimer were measured by use of latex-enhanced turbidimetry in an automated 
blood coagulation analyzer at the Karolinska University Hospital laboratory. Turbidimetry 
refers to the quantification of light scattering, causing loss of intensity of transmitted light, 
due to particles being suspended in a sample.  
3.7 IMMUNOHISTOCHEMISTRY 
 
Immunohistochemistry is a sensitive and specific method to detect and visualize the presence 
of a molecule in a tissue section by use of antibodies. This method involves deparaffinization, 
antigen retrieval (epitopes hidden during the fixation process are demasked with for example 
heating), blocking of unspecific antibody binding sites, addition of a primary antibody 
targeted at the protein of interest and subsequently a secondary antibody targeted at the first 
antibody after which an enzyme attached to the secondary antibody catalyzes a color-
producing reaction. The specificity depends on the specificity of the antibody and the 
blocking of unspecific binding, whereas the sensitivity comes from the performance of the 
antibody as well as the signal amplification produced by several secondary antibodies 
attaching to one primary with further amplification being possible in the following reactions. 
While immunohistochemistry is an excellent qualitative method to detect and localize 
specific proteins in a tissue section, its use for quantification is complicated by a number of 
conspiring sources of variation that are independent of the protein concentrations in the 
sample, from practically all steps of any protocol (346). Excellent guides on this methodology 
exist and the reader is referred to such for in-depth discussion (347).  
 
In project III, the primary antibodies were directed at E-XDP, neutrophil elastase and 
CD66acd, the latter used as a neutrophil marker (Table 4). Background blocking was 
performed by use of the commercial Background Sniper and antigen retrieval achieved with 
high-pressure boiling in DIVA buffer. Primary and negative control antibodies were diluted 
in Da Vinci Green solution and applied to tissue sections. Species-specific secondary 
antibodies followed and a probe-polymer system with alkaline phosphatase and its substrate 
Warp red, along with haematoxylin, were used for staining. All buffers and reagents were 
from Biocare (Concord, CA, USA) except for haematoxylin which came from Vector 
Laboratories (Burlingame, CA, USA). Slides were imaged in a microscope equipped with a 
digital camera (OPTIPHOT-2, Nikon Corp. Tokyo, Japan), as well as a slide scanner (Nano-
Zoomer, Hamamatsu Photonics, Hamamatsu City, Japan).  
 
Table 4: Antibodies used for immunohistochemistry in Paper III. 
Antibody Company Cat. nr Dilution Host 
Neutrophil elastase Neomarker Ms-1841-p 1/50 mouse 
E-XDP Cosmo Bio MKM-M16 1/2000 mouse 
CD66 BIORAD Mca1147g 1/50 rat 
 
3.8 MICROARRAYS 
 
A microarray is a solid surface covered with microscopic DNA probes, which can be used to 
simultaneously study the relative expression of a large number of genes. Two principal 
microarray methods exist, two-channel and one-channel. In two-channel arrays, two different 
samples of differing conditions, ie case and control, are labelled with two different 
fluorophores and are hybridized to the same microarray after which the relative balance 
between colors determines differential expression. In single-channel arrays, which were used 
in this thesis, intensity data is provided separately for each sample. In both cases, RNA from 
a sample is first reverse transcribed into cDNA which is transferred to the microarray where 
it hybridizes to the complementary probes. Samples are labeled before or after hybridization 
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depending on the type of microarray. After this step, scanning is performed and signal 
intensity for each probe is measured. Commonly, several probes targeting the same transcript 
are randomly distributed across the chip and this group is referred to as a probe set. In the 
case of both two- and one-channel microarrays, the output data intensity does not correlate 
linearly with the RNA concentration in the original sample. The values are relative to other 
samples in the same batch. A data post-processing step is thus required in which probes are 
summarized into probe sets and where data is normalized and transformed. In this thesis, data 
was processed through probe sets summarization, guanine cytosine count normalization, in 
which probe affinity variations associated with GC-content was adjusted for, signal space 
transformation, where the intensity distribution is stretched to counteract fold change 
compression seen in microarrays, followed by standard robust multi-array average including 
background correction, quantile normalization, log transformation and median polish (348–
350). Advantages of microarray is that it is a fast and increasingly affordable method while 
able to quantify hundreds of thousands coding and non-coding transcripts, including the 
analysis of alternative splicing. However, quantification remains relative and transcripts need 
in principle to been known before-hand in order to design the chip.  
 
In study IV specifically, samples were procured and preserved according to section 3.2. 
Tissue RNA was extracted using Qiazol Lysis Reagent and subsequently purified by use of 
RNeasy or miRNeasy minikits (Qiagen, Hilden, Germany). The RNA concentrations were 
measured with the Nanodrop ND 1000 (Thermo Fisher Scientific, Waltham, MA, USA) and 
quality assessed as RNA integrity numbers by Bioanalyzer (Agilent Technologies, Santa 
Clara, CA, USA). Samples with purified RNA of identical concentrations were analyzed with 
Human Transcriptome Array 2.0 microarrays (Thermo Fisher Scientific) at the 
Bioinformatics and Expression Analysis core facility at Karolinska Institutet in Stockholm, 
Sweden. The resulting raw data were normalized and quality-controlled by use of the 
Transcriptome Analysis Console software (Thermo Fisher Scientific). 
3.9 BIOINFORMATICS 
 
A modern microarray experiment yields the relative quantities of tens of thousands of coding 
and non-coding transcripts. In order to extract biologically relevant information from this 
data, bioinformatic tools have been developed to study if there is an underlying structure 
between arrays and if this may be coupled to the condition of interest. Such analyses include 
unsupervised and supervised clustering, testing if genes significantly different between cases 
and controls, which biological processes are overrepresented, ‘enriched’, among these genes 
and if regulating transcription factors can be identified. Further, the normal tissue expression 
of a gene is available from databases cataloging large RNA sequencing efforts and the 
relative abundance of immune cell subsets can be quantified with specific algorithms 
(351,352). 
 
In paper IV, t-SNE and OPLS-DA, described in section 3.5, were used for unsupervised and 
supervised clustering, respectively. Differential expression between two conditions was 
queried with linear models for microarray and RNAseq data (limma), which is a flexible R 
package that fits a linear model for each gene and utilizes the empirical Bayes procedure by 
adjusting the variance of an individual gene for the global variance of all genes, increasing 
the effective degrees of freedom (353). The limma approach also allows for multiple 
regression models, and comparisons between AAA and controls were thus corrected for age 
and sex. Paired tests were made between tissues from the same subject. In order to control 
the number of false positives when performing thousands of comparisons, we used false 
detection rate (FDR) threshold of less than 0.05, meaning that a maximum of 5% positives 
are false positives. Two approaches were used for gene set enrichment of the resulting list of 
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up- and downregulated genes, Enrichr and Broad Institute Gene Set Enrichment Analysis 
(GSEA). Enrichment was searched for in gene set databases Gene ontology biological 
processes (GO:BP) and Molecular functions (MF) as well as Molecular signatures database 
(MSigDb) Hallmark dataset. Enrichr is a threshold-dependent method that looks for 
overrepresented gene sets in a list of genes by a combination of Fisher exact test and the 
deviation from the expected rank of a term in a random search of each database (215,354). 
In GSEA, on the other hand, no threshold is used and the ranked order, based on fold change 
for instance, of all genes is searched for gene sets overrepresented at the extreme ends, 
normalized to the size of the gene set (216). Both methods used FDR to correct for multiple 
comparisons. Relationships between enriched GO:BPs and GO:MFs were visualized with 
Cytoscape based on the number of genes in common normalized by the size of the smallest 
gene set (355). Normal tissue expression and immune cell subset enumeration were examined 
by use of the Genotype-Tissue Expression (GTEx) database (351) and CIBERSORT (352), 
respectively. Transcription factor enrichment was performed by use of ChIP-X Enrichment 
Analysis 3 (ChEA3), which ranks transcription factors associated with a supplied gene list 
based on publicly available libraries including transcription factor-gene coexpression in 
RNA-seq studies and transcription factor-target associations from chromatin 
immunoprecipitation-sequencing experiments (356). 
3.10 OTHER STATISTICAL METHODS 
 
Unless stated otherwise, continuous data is described as median (interquartile range, IQR, or 
min-max) and categorical data as number (percent). The nonparametric Mann-Whitney U / 
Wilcoxon rank-sum or Kruskal-Wallis tests were used when normal distribution could not be 
assumed. The t-test was used after Pearson-D’Agostino omnibus testing for normality in 
paper II and to compare ages between groups in paper IV. Differences in distributions of 
categorical data were evaluated with chi-squared tests. Correlations between continuous 
variables were generally evaluated by use of Spearman’s rank correlation coefficient, which 
is nonparametric and does not rely on normal distribution while being able to detect both 
linear and nonlinear monotonic correlations. When the relationships between absolute values 
themselves were important, such as with continuous predictions in study II, the parametric 
Pearson correlation coefficient was used. Differences between correlation coefficients were 
tested with R package cocor (357). Classification performance was studied with receiver 
operating characteristic (ROC) curves, the areas under which were compared by use of the 
Delong algorithm as implemented in the pROC R package (358). Reproducibility was 
evaluated according to Bland and Altman (359). All data analysis, except for that involving 
bioinformatic tools requiring interaction with a desktop or web application, were conducted 
in R (360) or Prism (GraphPad Software Inc, San Diego, CA, USA). 
3.11 STUDY DESIGNS 
3.11.1 Study I 
 
Patients with AAA (n = 146 included from 337 screened patient records) were retrospectively 
identified after having been managed at our outpatient clinic between 2009-2013 with the 
inclusion criterion of having undergone 1 CTA of an AAA with a clinical diameter between 
40 and 60 mm and the exclusion criteria of incomplete patient characteristics data as well as 
reasons listed in section 3.1. All CTAs underwent geometric analysis and FEA as described 
in section 3.3. Two types of FEA were performed. In the neutral analysis, the FEA software 
was supplied uniform data, ie remained uniformed of patient sex, age, family history and 
blood pressure. In the specific analysis, these values were supplied. The PWRI was converted 
to an RRED according to section 3.3, in order to facilitate interpretation of coefficients.  
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Simple and multiple linear regression analyses were conducted to study associations between 
PWS, RRED, patient characteristics and aneurysm geometry. Two and three multiple 
regression models with PWS and RRED, respectively, as dependent variables were created; 
model A with patient characteristics, model B with patient characteristics and aneurysm 
geometry and model C with patient characteristics, aneurysm geometry and PWS as 
independent variables. Patient characteristics were age, gender, smoking, MAP, height and 
weight (or BMI and BSA, (361) in separate models due to collinearity), and geometric 
features were semiautomatic maximal diameter, ILT volume and lumen volume. Diagnostic 
plots were inspected to detect nonlinearity, non-normality, heteroscedasticity and highly 
influential outliers in the regression models.  
3.11.2 Study II 
 
Patients with AAA (n = 191 included from 1172 screened patient records) were included 
consecutively by use of two search strategies; 1) a list of all patients with a diagnosis of AAA 
and a registered CT between 2009-2013 and 2) by going through lists of all patients who had 
presented to our outpatient clinic with an AAA between 2012 and 2013. Inclusion criterion 
was an AAA with a maximal clinical diameter at baseline of 40-50 mm imaged by CTA at 
least four years prior to the record review date and exclusion criteria were according to 
section 3.1. Of the 191 patients, 173 had complete follow-up data and 163 had two CTAs 
performed with an 8 month to 8 year interval. Growth predictions were studied in the latter 
group.  
 
Patients underwent geometric and biomechanical analysis of CTAs as described in section 
3.3. Reaching the threshold for surgery was defined as the AAA reaching 55 mm diameter if 
the patient was male, 52 mm if female (which has been the current practice at our department 
for the last decade), being surgically treated at smaller diameters or the occurrence of rupture 
or symptomatic AAA. Conversely, the aneurysm was considered Stable if it was intact and 
asymptomatic with a diameter below 55 mm in males and 52 mm in females after four years. 
Patients who had incomplete follow-up due to dying from unrelated causes or considered too 
frail for surgery were included in the Stable group. Growth rates of the clinical diameter, as 
measured by radiologists or vascular surgeons, the semiautomatic diameter and vessel 
volume, as calculated by the FEA software, were calculated in patients with two available 
CTA by use of growth equations described in section 3.4.  
 
All variables were used in the prediction modeling in addition to the clinical diameter. All 
predictions of growth and indication for surgery were performed under 10-fold cross-
validation, please refer to section 3.5. Multivariable models used were logistic and linear 
regression for prediction of indication for surgery or growth rates, respectively, as well as 
ridge regression, LASSO and SVM with a linear or radial basis function kernel for both 
outcomes. Tuning was performed by 10-fold cross-validation with 3 repeats. All predictions 
were repeated 100 times and average predictions were used for evaluation. All modeling and 
variable importance analyses were conducted with R package caret (362). Ruptured and 
symptomatic AAAs were too few to allow multivariable modeling or cross-validation. 
Classification was evaluated with ROC analysis and correlations between continuous 
predicted and observed values were tested with the Pearson’s correlation coefficient. 
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3.11.3 Study III  
 
Blood samples were drawn prior to elective aneurysm repair from 37 male patients with AAA 
and 42 age- and sex-matched controls, the latter identified via AAA screening as described 
in section 3.1. Patient data were collected from the electronic medical records and CTA 
images were download from the hospital picture archiving and communication system. The 
CT images of this main cohort were analyzed by use of A4clinics Research Edition as 
described in section 3.3, while also using this software to segment the ILT volume of all 
coexisting aneurysms. To validate the findings, a separate cohort of 51 patients with AAA 
was studied and the volumes of their ILTs were measured by standard ‘manual’ segmentation 
using the Leonardo Workstation (Siemens AG, Berlin and Munich, Germany). Circulating 
levels of E-XDP and D-dimer were measured with sandwich ELISA and turbidimetry, 
respectively, as described in section 3.6.  
 
The relationship between AAA and E-XDP was tested by comparing circulating levels in 
cases and controls, ROC testing of classification performance, multiple regression to 
investigate if E-XDP levels were affected by patient characteristics other than the presence 
of an AAA and correlation tests relating E-XDP levels to aneurysm geometry and 
biomechanics. We also studied the more traditional marker of fibrinolysis, D-dimer, in 
parallel and tested which of these two markers that showed the strongest association with 
AAA. In the validation cohort, E-XDP and D-dimer levels were correlated with the ILT 
volume and the clinical AAA diameter. 
 
In order to verify that the circulating E-XDP originated from ILT degradation by neutrophil 
elastase activity, these entities were stained specifically, by use of immunohistochemistry as 
described in section 3.6, in vessel wall from AAAs and organ donor controls. 
3.11.4 Study IV 
 
Tissue samples from AAA and control aorta were compared and the effect of the ILT, patient 
smoking status and the aneurysm progression rate were investigated, while taking age and 
sex into account. Patients and controls with the highest RNA integrity number were selected 
from the biobank. Patients with both ILT-covered and -free vessel wall available and controls 
in similar age groups as the patients were prioritized. A total of 246 aortic tissue samples, 
dissected into tunica media and adventitia, from 76 patients with AAA and 13 organ donor 
controls were collected and preserved as described in section 3.2. These samples were 
analyzed with microarrays as described in section 3.8. The resulting normalized and log-
transformed data was subjected to bioinformatic evaluation according to section 3.9.  
 
Specifically, samples of AAA and controls were compared with adjustment for age and sex, 
which lead to identification of a large number of differentially expressed genes. These results 
were compared to those of previously published microarray studies on AAA tissue (113,217). 
In order to make functional interpretations of the large number of dysregulated genes, gene 
set enrichment analysis and transcription factor prediction was performed as described in 
section 3.9. Further, the tunica-specific approach allowed comparison of media-adventitia 
relationships in AAA and controls. As such, genes upregulated in adventitia compared with 
media in controls, while to the opposite being upregulated in media compared with adventitia 
in AAAs, were cross-referenced against genes dysregulated between AAA and controls, 
revealing a group of disease-associated genes switching tunica predominance from adventitia 
in normal aorta to media in AAA disease. In the next step, the transcriptomic effects of an 
overlying ILT, active smoking and the diameter growth rate were examined. The media and 
adventitia of thrombus-covered and thrombus-free AAA wall were compared in a pairwise 
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manner, including only patients from whom both ILT-covered and ILT-free wall were 
available. Comparisons were also made, separately for AAA and control samples, between 
subjects actively smoking and those that did not. Finally, in patients imaged twice with a 10 
to 26 months interval by the same modality (US or CT), with the final imaging instance being 
pre-operative, the diameter growth rate was correlated with the expression of each gene. 
Enrichment analysis resources Enrichr (215,354,363) and GSEA (216) were used when the 
significantly dysregulated genes withstood adjustment for multiple comparisons whereas 
only GSEA was used when no genes did. 
3.12 ETHICAL CONSIDERATIONS 
 
All studies were performed according to the declaration of Helsinki and were approved by 
the local ethics review board. In study I and II, patient records and coded, anonymized CT 
images were analyzed without informed consent. This was motivated by on the one hand the 
minimal intrusion into patient privacy a retrospective patient record review constitutes, and 
on the other hand the expected loss of material if prior informed consent was needed due to 
the high age and common comorbidities of the typical AAA patient. In study III and IV, there 
was a prospective collection of blood and tissue into a biobank, requiring informed consent. 
The extra blood samples taken for research purposes was considered a minimally invasive 
procedure. The collection of tissue from the aortic wall could theoretically affect the closure 
of the aneurysm sac over the graft and care was therefore given to only excise excess vascular 
tissue. The organ donors agreed to the usage of tissue samples for research purposes at the 
time of enrollment into the organ donor registry and the extraction of aortic tissue did not 
significantly affect organ extraction procedures.  
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4 RESULTS AND DISCUSSION 
 
Table 5: Overview of study results.  
Study Objective Results 
I. To study the association between clinical 
rupture risk factors, geometry and 
biomechanical rupture risk indices. 
Female sex, patient height and BSA were positively, 
and BMI negatively, associated with RREDneutral in a 
PWS-dependent manner. Adjusting for PWS revealed 
smoking as a significant covariate. These effects were 
independent of maximal diameter and in the 
RREDneutral, FEA had not been informed of patient 
characteristics. Lumen volume showed strong 
associations with PWS and RRED. 
 
II. To study if geometric or biomechanical 
modeling in small AAAs could improve 
predictions of which patients would 
reach the threshold for surgery within 
four years, their aneurysms’ future 
growth rate and the occurrence of 
rupture or symptomatic AAA. 
Increased precision in diameter measurements 
improve prediction of growth and future indication 
for surgery in small AAAs. However, including 
additional geometric and biomechanical indices with 
regression and machine learning techniques did not 
improve these predictions. Lumen diameter, PWS and 
PWRI were the only significant predictors of the few 
cases of future rupture or symptomatic AAA. Growth 
and rupture require different prediction models. 
 
III.  To study E-XDP as a marker of 
neutrophil-induced degradation of the 
aneurysm-related ILT as well as to 
evaluate to what extent this marker is 
associated the ILT and aneurysm 
volume, diameter and biomechanical 
rupture risk. 
E-XDP is a sensitive marker of AAA, independently 
of smoking, investigated comorbidities and 
medication. E-XDP correlated with ILT volume, 
mean ILT stress and the AAA diameter. It was 
positively associated with presence of co-existing 
aneurysms outside the abdominal aorta. The 
correlation between E-XDP and ILT volume was 
stronger than between D-dimer and ILT volume. 
 
IV. To detect novel pathophysiologic 
features of AAA by tunica-specific 
microarray analysis of the genome-wide 
expression of genes in ILT-free and -
covered aspects of the human AAA wall. 
A large number of genes were differentially 
expressed between AAA and controls, many of which 
were unique to either media or adventitia. Pathways 
related to inflammation were transmurally 
upregulated whereas a pattern comprising 
upregulation of proteolysis and angiogenesis with 
downregulation of vSMC- and differentiation-related 
pathways were specific for media. The ILT had a pro-
inflammatory and -proteolytic effect. Smoking caused 
aneurysm-like gene expression in control arteries. 
Growth rate correlated with B- and T-cell-related 
gene expression in media, and lipid pathways in 
adventitia. 
 
4.1 STUDY I – GENDER, SMOKING, BODY SIZE, AND ANEURYSM 
GEOMETRY INFLUENCE THE BIOMECHANICAL RUPTURE RISK OF 
ABDOMINAL AORTIC ANEURYSMS AS ESTIMATED BY FINITE ELEMENT 
ANALYSIS. 
 
The AAA maximal diameter is an imperfect risk indicator and it has been observed that 
patients with AAAs of similar diameter have differing risks of rupture, suggesting that other 
factors need to be taken into account (19,21,61). Identified clinical risk factors for rupture 
include female sex, active smoking, high blood pressure, old age and low BMI (19,21). An 
emerging method proposed to increase precision of rupture prediction is FEA, described in 
section 1.5, which estimates biomechanical risk indices PWS and PWRI or RRED. In study 
I, it was investigated to what extent there was a biomechanical explanation for these clinically 
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observed risk factors. The FEA was performed both uninformed, ‘neutral’, and informed, 
‘specific’, about patient characteristics. We also aimed to find which geometrical variables 
were most important for the biomechanical state of the aneurysm.  
 
Results 
 
In multiple regression analysis, it was found that PWSneutral was associated with patient height 
and female sex, PWSspecific with patient height and blood pressure, and that both were 
positively associated with maximal diameter and lumen volume, while negatively associated 
with ILT volume (Table 6). These results suggest that the biomechanical stress on the 
aneurysm wall, not considering its strength, is generally increased in taller patients as well as 
in females. A larger ILT, a smaller diameter and a smaller lumen decrease the wall stress.  
 
Multiple regression was performed with RRED, which considers both wall stress and wall 
strength and converts their ratio into a diameter value of corresponding rupture risk, as the 
dependent variable. Both RREDneutral and RREDspecific increased in patients with female sex, 
tall stature and who were actively smoking (Table 7). Female sex and height elevated 
RREDneutral in a wall stress-dependent manner. Female sex also remained a significant 
covariate in RREDspecific after adjustment for PWS, corresponding to the way in which wall 
strength is calculated by the software. Smoking, which is not considered by the software, 
appeared to decrease wall strength, as it significantly increased RREDneutral and RREDspecific 
after adjustment for wall stress. Geometric factors elevating RRED were maximal diameter 
and lumen volume. When adjusting for PWS, increasing ILT size contributed to an increased 
RRED.  
 
When height and weight were replaced by BSA and BMI, it was found that BMI correlated 
negatively with PWS and RRED whereas the opposite was true for BSA. The effect of lumen 
volume on RRED can be qualitatively appreciated in Figure 15, which displays two 
Table 6: Multiple linear regression models for peak wall stress. 
Model A Model B Model A Model B
Independent PWSneutral PWSneutral PWSspecific PWSspecific
Age, years old
Female sex
Tobacco smoking (Current)
Family history (Yes)
Height, cm
Weight, kg
MAP, mmHg
Max diameter of 3D model, mm
ILT volume, cm3 - -
Lumen volume, cm3 - -
R2 = 0.35 *** R2 = 0.69 *** R2 = 0.51 *** R2 = 0.75 ***
Dependent
Covariates included in multiple regression were; model A: patient demographics and diameter, model 
B: model A, ILT and lumen volume. Stronger shading represents a more significant effect on the 
model (lower p-value), red represents a positive and blue a negative coefficient.
Abbreviations; 3D: three-dimensional, ILT: intraluminal thrombus, MAP: mean arterial pressure, 
PWS: peak wall stress
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aneurysms of similar diameter that nevertheless have among the lowest (A) and highest (B) 
estimated RRED in the study. The effective lumen is small and wall stress is cushioned by a 
thick circumferential ILT in Figure 15A, whereas the aneurysm in Figure 15B does not 
benefit from the same geometry. 
 
 
 
 
 
 
 
Figure 15: Aneurysms with differing biomechanical rupture risk despite similar maximal diameter. 
Cross-sections of two AAAs with the lowest (A) and highest (B) biomechanical rupture risks of the study 
despite both having diameters of approximately 55 mm.  
Table 7: Multiple linear regression models for rupture risk equivalent diameter 
 
Model A Model B Model C Model A Model B Model C
Independent RREDneutral RREDneutral RREDneutral RREDspecific RREDspecific RREDspecific
Age, years
Female sex
Tobacco smoking (Current)
Family history (Yes)
Height, cm
Weight, kg
MAP, mmHg
Max diameter of 3D model, mm
ILT volume, cm3
Lumen volume, cm3
PWSneutral, kPa - - - - -
PWSspecific, kPa - - - - -
R2 = 0.39 *** R2 = 0.69 *** R2 = 0.92 *** R2 = 0.65 *** R2 = 0.82 *** R2 = 0.91 ***
Dependent
Covariates included in multiple regression were; model A: patient demographics and diameter, model B: model A, ILT and lumen 
volumes, model C:, model B and peak wall stress. Stronger shading signifies a more significant effect on the model (lower p-value), 
red represents a positive and blue a negative coefficient. 
Abbreviations: 3D: three-dimensional, ILT: intraluminal thrombus, MAP: mean arterial pressure, PWS: peak wall stress, RRED: 
rupture risk equivalent diameter
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Discussion 
 
Several results of the present study were intriguing. First, female sex is a strong clinical risk 
factor for rupture of AAA and it has previously been shown that female patients have weaker 
vessel walls compared with male patients (253). As a result, RRED is increased in women 
when informing the software of the patient sex (364). However, the present study observed 
that female sex was associated with increased PWSneutral and RREDneutral, ie were the software 
does not have information about patient characteristics but only the CTA-derived geometry. 
This implies that female sex is not only associated with a weaker vessel wall but also a 
biomechanically unfavorable aneurysm and ILT geometry. Patient height or BSA were also 
associated with an increased PWSneutral and RREDneutral with similar implications that tall or 
larger patients have a less stable aneurysm geometry compared with their shorter 
counterparts. While patient height is not typically described as a rupture risk factor for AAA, 
it has been linked to AAA prevalence and aortic rupture (365,366). The latter study did not 
specifically examine rupture of the abdominal aorta and it was not known to what extent 
ruptures were associated with diseases like Marfan syndrome, that also cause increased body 
height, but the sample’s mean age of 55 and the much higher prevalence of common AAA 
make it unlikely that the entire association can be explained by connective tissue disorders. 
The observed inverse association between BMI and PWS/RRED agrees with clinical 
observations (21) and it has been proposed that the aneurysm diameter should be considered 
relative to body size (206,207). While these results and others make a case for taking an 
interest in the relative aneurysm diameter, it is not known if it should be related to height, 
BMI or BSA. Age showed no correlation with PWS or RRED, despite being associated with 
rupture in a large meta-analysis but not in the largest included study (19,21). Female patients 
were significantly older than their male counterparts in the present study and such an 
underlying confounder was not excluded in the large meta-analysis.  
 
The most important geometric factor of the present analyses was lumen volume. The size of 
the AAA lumen has since been recognized as a risk modifier in AAA disease, congruent with 
the findings above (277,367). Further, the dual role of the ILT became apparent as it cushions 
against wall stress but, given the same stress, weakens the wall and increases the 
biomechanical risk index. An important assumption when considering lumen and ILT 
geometry and biomechanics is the structural integrity of the ILT. As discussed in section 
1.3.3, mechanical failure of the ILT would increase stress in an already weakened vessel wall 
(295) and taking radiological signs of ILT crack propagation (296–298) into account could 
improve estimations of PWS and PWRI/RRED.  
 
Due to the complexity of biological tissue and organs, along with consideration of 
computational cost as well as our incomplete knowledge about relevant processes and 
properties, biomechanical modeling requires assumptions and simplifications. The employed 
FEA software does not consider blood flow, residual stresses, wall calcifications, interactions 
with surrounding organs or porosity of the ILT while it consider the vessel wall to be 
isotropic, in contrast to observed anisotropy, and relies on average constitutive properties 
based on uniaxial tensile testing (240,249,253,273,289,334,338). However, given above 
constraints, a finite element model should only be complex enough to fulfill its intended 
application. The intended application of this FEA is to predict rupture and features that 
increase complexity without improving diagnostic precision should not be included. Blood 
flow requires extensive fluid-structure interaction modeling but resulting effect on wall stress 
appears to be negligible compared with FEA without modeling of flow (368). Wall 
calcifications are easy to recognize on CT but the resulting effect on wall stress depends on 
how the calcification and its interaction with surrounding wall are modeled, with conflicting 
biomechanical and clinical results in the literature (369–373). While mild anisotropy has been 
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observed in AAA tissue, anisotropic and isotropic FEA performs similarly (240,374). 
Patient-specific constitutive models of vessel wall behavior are intuitively appealing but it 
has been shown that varying tissue properties within the 95% confidence interval resulted in 
≤ 4% change in computed wall stress, motivating the use of average constitutive descriptions 
(328). Neglecting the impact of surrounding organs, residual stresses and mechanobiological 
responses to stress could be important limitations to the used FEA and considering these 
factors may improve stress predictions (375–377). Finally, respecting the non-linear behavior 
of the vessel wall, having a high level of geometric precision in the 3D reconstruction and 
including the ILT, which the FEA used in this thesis does, appears to be important for 
accurate stress predictions (273,378,379).  
 
In summary, these results show that female sex, smoking, increased height or low BMI as 
well a large lumen volume are associated with significantly increased wall stress and rupture 
risk indices, giving in part a biomechanical explanation to observed clinical risk factors. 
Importantly, these associations were found even in analyses where the software was 
uninformed about patient characteristics.  
 
4.2 STUDY II – GEOMETRIC AND BIOMECHANICAL PREDICTION MODELING 
OF GROWTH, TREATMENT AND OUTCOME OF SMALL ABDOMINAL 
AORTIC ANEURYSMS USING MACHINE LEARNING. 
 
After having established that there appeared to be a biomechanical foundation for clinically 
observed rupture risk factors, and that several geometric variables were independently 
associated with the risk of rupture, study II focused on using FEA and geometry in 
multivariable models to try to increase the prediction of outcome of AAAs. The FEA 
software considers the entire geometry of the AAA and outputs a comprehensive set of 
geometric and biomechanical variables, most of which have not been studied with respect to 
AAA outcome prediction. Further, the relationships between these variables could be 
complex or non-linear and with the use of many variables in the same prediction model there 
is a risk of over-fitting. In parallel with the development of FEA, algorithms for complex 
statistical learning have been made increasingly available, shown to be effective and are 
increasingly used in a wide variety of research applications, including cardiac and AAA 
imaging (336,337,341,380). As such, multivariable modeling, tuning by machine learning 
protocols and cross-validation to estimate performance outside the present dataset were used 
as described in section 3.5 in order to effectively and robustly utilize the available output data 
from FEA to predict future outcome of AAA. 
 
Results 
 
Of the 191 patients, 103 remained stable and 88 reached the threshold for surgery in four 
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Multivariable models, utilizing machine learning algorithms and incorporating all 
geometrical and biomechanical output from the FEA software, were superior compared with 
the clinically measured diameter at predicting the four-year outcome (Figure 17A). 
Specifically, the area under curve (AUC) for the best performing multivariable model, 
compared with that of the reference model, was 0.85 vs 0.80 (p = 0.031). As an example, the 
best model could achieve 100% sensitivity and 21% specificity, whereas the reference model 
did not reach 100% sensitivity. Only lumen volume, PWS and PWRI could significantly 
predict which patients would suffer from ruptured or symptomatic AAA (Figure 17B). 
Multivariable models also improved prediction of diameter growth rate, (r = 0.38, p = 6.1e-
07 for the best-performing model and r = 0.17, p = 0.033 for clinical diameter reference, 
correlation comparison p = 0.0031, Fig 17C). There was a trend towards improved prediction 
of volume growth rate (Figure 17D). The most influential variable was the semiautomatic 
diameter measured from the FEA software and by only using the clinical and the 
semiautomatic diameters as predictors, similar predictive power for diameter growth rate and 
four-year outcome and was obtained as with the more complex models (not shown). 
 
Discussion 
 
These findings suggest that a semi-automatic measurement of the aneurysm diameter, based 
on a 3D model, can significantly improve the precision of AAA growth rate prediction. No 
support was found for adding additional geometric and biomechanical variables to this end. 
Figure 16: Overview of study design and outcomes.  
Abbreviations; CV: cross validation, ILT: intraluminal thrombus, PWRI: peak wall rupture index, PWS: 
peak wall stress, WS: wall stress. 
*: Patients were censored if they died from unrelated causes or follow-up was terminated before surgery.  
†: Included prediction models were multiple linear/logistic regression, ridge regression, least absolute 
shrinkage and selection operator as well as support vector machines with linear and radial basis function 
kernels. 
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The contrasting finding of PWS, PWRI and lumen volume as the only significant rupture or 
aneurysm symptom predictors imply that predicting growth and rupture of small AAAs 
require different models.  
 
A large number of promising markers of presence, size, growth and rupture of AAAs have 
been previously described, as discussed in section 1.5. Employed methods include geometric 
analysis (290,300,307), FEA (270,271,273–276,332,333), biomarkers (316) and tracers for 
PET-CT (310,311,315) or MRI (314). However, none these markers have thus far been used 
clinically as replacement for or addition to diameter and female sex, motivating a critical 
appraisal. In many studies, the findings have not been validated, for example by division of 
data into training/test sets, cross-validation or external validation etc and even if the marker 
itself has been examined in more than one study, specific thresholds have seldom been 
established. Further, any clinically meaningful prediction study should compare the new, 
presumably more complex algorithm with the performance of already existing ones (ie 
clinical diameter measurements). Few AAA prediction studies manages to check both of 
these boxes with favorable results. So far, most investigations have also been limited to a 
single or only very few predictors per study.  
 
The present study sought an effective and robust approach to prediction modeling in AAA 
disease, with principles explained in section 3.5. The results revealed that slight but 
significant improvements can be achieved to predict growth and future need for surgery 
compared with the currently used clinical diameter but also that most included variables were 
Figure 17. Prediction of reaching surgical threshold within four years, future rupture or 
symptomatic AAA and growth rate. A: ROC analysis of predictions by multivariable models including 
all variables, AUC below each variable. B: ROC analysis for prediction of future rupture or symptomatic 
aneurysm. The AUC (95% confidence interval) is presented below each variable. C: Prediction of 
diameter and volume growth rate.  
Abbreviations; AUC: area under curve, CV: cross-validated, ILT: intraluminal thrombus, LASSO: least 
absolute shrinkage and selection operator, PWRI: peak wall rupture index, PWS: peak wall stress, ROC: 
receiver operating characteristic, SVM: support vector machine with linear or radial basis function kernel,  
WS: wall stress 
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not independently informative. Additional analyses not described in Results were performed 
in which cross-validation was ignored and prediction algorithms were tested on the same data 
it was trained on. In these analyses, the multivariable machine learning models achieved near 
perfect results, with a large share of included variables contributing to the predictive 
performance. This emphasizes the need for external validation, and may explain why markers 
that have not been tested outside the dataset they were developed from, often fail to reach 
clinical relevance. The framework used in the present study could in the future include 
clinical characteristics, biomarkers available from peripheral blood and imaging tracer 
markers. 
 
The major limitation of the present study is its sample size and retrospective nature. While it 
was large compared with previous FEA studies, and at level with several successful cardiac 
CT studies (380), there is a clear correlation between the size of a training set and the 
diagnostic performance of resulting algorithms (381). With a larger number of included 
patients and prospectively determined protocols and imaging intervals, the performance in 
the current study would most likely increase and some variables would potentially become 
more informative. The present study also used a simplified approach in which descriptors of 
geometry and biomechanics were used rather than the geometry itself, such as with training 
on a 3D model of the aneurysm, a map of spatial distribution of mechanical load or even the 
entire CT image. With a larger sample size and less reduced descriptions of the AAA, widely 
applied systems such as artificial neural networks could become effective despite showing 
poor predictive performance on the present material (not shown).  
4.3 STUDY III – NEUTROPHIL ELASTASE-DERIVED FIBRIN DEGRADATION 
PRODUCTS INDICATE PRESENCE OF ABDOMINAL AORTIC ANEURYSMS 
AND CORRELATE WITH INTRALUMINAL THROMBUS VOLUME. 
 
The results from study II showed that 3D geometric and biomechanical modeling improves 
prediction of outcome compared with the currently used clinical diameter. However, most 
used variables were not independently informative and much room for improvement 
remained. In study III, the scope was broadened to include biological markers for future use 
to facilitate diagnosis and improved outcome prediction of AAA. Most clinically relevant 
AAAs contain an ILT, which traps neutrophils. As elaborated on in section 3.6, the 
degradation of fibrin by neutrophil elastase results in a specific degradation product, E-XDP. 
It was hypothesized that E-XDP produced in the ILT is a marker of AAA and ILT presence, 
size and biomechanical rupture risk, and that it is superior in this respect to the widely 
available D-dimer. 
 
Results 
 
The employed antibody was shown to specifically bind E-XDP and not plasmin-derived 
fibrin degradation products. E-XDP was significantly increased in the peripheral blood of 
patients with AAA compared with controls (Figure 18A) and a ROC analysis showed an 
excellent accuracy of this potential biomarker, with an AUC of 0.97 and the possibility to 
attain 98% sensitivity and 86% specificity to diagnose AAA by use of E-XDP (Figure 18B). 
This difference in E-XDP levels between AAAs and controls remained when only AAA with 
thin ILTs were included. Multiple regression revealed that E-XDP was independently 
associated with the diameter of the AAA and the presence of aneurysms outside the infrarenal 
aorta, while not being affected by smoking, prescription drugs or comorbidity.  
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Supporting the ILT as a source of E-XDP as well as its use for prognostic information, there 
was a strong correlation between E-XDP levels and the total ILT volume (ie the sum of all 
ILTs of all aneurysms in a patient), AAA ILT, AAA maximal diameter and the mechanical 
stress in the ILT in the patient group (Figure 19). D-dimer also correlated significantly with 
ILT of all aneurysms and that of the AAA but to a significantly weaker degree than E-XDP. 
There was no association between E-XDP and PWS or PWRI. Further, E-XDP was not a 
marker of general low-grade inflammatory activity, as it did not correlate with C-reactive 
protein or leukocyte count. The relationship between E-XDP and ILT volume, but not that 
between E-XDP and AAA diameter, could be validated in the separate cohort. In this cohort, 
there was a much weaker relationship between ILT volume and diameter. Finally, by use of 
immunohistochemistry a strong presence of E-XDP in the vessel wall-thrombus and vessel 
wall-lumen interfaces were observed in AAA but not control specimens. 
Figure 18. E-XDP as a marker of abdominal aortic aneurysm presence and size. A: Violin plot with 
logarithmic y-axis of E-XDP levels in controls and patients with AAA, difference tested with Wilcoxon 
rank-sum test. B: ROC analysis of the ability of E-XDP to distinguish AAA from controls. C: Correlation 
between E-XDP and the clinical maximal diameter, tested with Spearman’s rank correlation coefficient.  
Abbreviations; AUC: area under ROC curve, E-XDP: neutrophil elastase-derived fibrin degradation 
products, ROC: receiver operating characteristic.  
Notations; ***:p<0.001. 
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Discussion 
 
This study is the first to describe E-XDP as a marker of AAA and establishes a close 
relationship between E-XDP levels and the ILT. The results also imply that E-XDP could be 
used to detect any large arterial aneurysm and that they could be detected even with thin 
ILTs. As such, the inner surface area of the aneurysm as well as the volume of the ILT could 
both important for the production of E-XDP. 
 
The rationale behind the use of E-XDP was that most clinically relevant AAAs contain an 
ILT, which traps neutrophils expressing elastase. The specific degradation product of fibrin 
from elastase, E-XDP, was hypothesized to be more specific than that produced by plasmin, 
D-dimer, which has been studied as an AAA marker previously (322). Above results support 
this notion, with observed ROC curves of 0.97 and 0.89 as well as correlations between 
marker concentrations and ILT volume of r = 0.76 and r = 0.64 for E-XDP and D-dimer, 
respectively.  
 
Some limitations of this study merit consideration. We only had access to male 65-year-old 
control subjects as this is the only group invited to screening. As such, applying the 
sensitivities and specificities of the current study to female patients would constitute 
extrapolation. On the other hand, the validation group included women and showed clear 
correlations between E-XDP concentration and ILT volume. Mean ILT stress is calculated 
based on previous ex vivo biomechanical testing, based on the same principles as the well-
studied PWS and PWRR/RRED, but this measurement has not been specifically evaluated. 
It is also worth noting that while the relationship between E-XDP and ILT volume was 
validated in external data, the thresholds to differentiate between AAA and controls were not, 
necessitating future investigations before clinical implementation. 
 
Figure 19. E-XDP as a marker of ILT volume, diameter and mean ILT stress. Sizes of dots 
correspond to the semiautomatic maximal diameter of the AAA, shades represent mean ILT stress. 
Volume of the ILT was normalized against estimated blood volume. 
Correlation tested with Spearman’s rank correlation coefficient.  
Abbreviations; EBV: estimated blood volume, E-XDP: neutrophil elastase-derived fibrin degradation 
products, ILT: intraluminal thrombus.  
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While a circulating biomarker of AAA presence and size is easily outcompeted by the widely 
accessible, non-invasive and precise US examination in a high resource-setting, such a 
biomarker could find additional uses. A sensitive biomarker could be used as a screening tool 
in locations were US equipment is not available or as a quick test to exclude the presence of 
large aneurysms. Further, a biomarker of the contact between ILT and circulating blood could 
potentially be used to detect endoleaks after EVAR treatment. Future studies should also 
investigate whether the E-XDP could give information about the mechanical integrity of the 
ILT, as suggested by the correlation of E-XDP and the mean ILT stress, or if it could predict 
growth. Importantly, however, AAA is not the only condition affecting E-XDP levels. It has 
been seen to rise with sepsis, acute leukemia, deep venous thrombosis and disseminated 
intravascular coagulation (344,382,383). These factors affect the specificity but not 
sensitivity of E-XDP which was high. As such, this marker seems more poised to rule-out, 
rather than rule-in, AAA. 
4.4 STUDY IV – TUNICA-SPECIFIC TRANSCRIPTOME OF ABDOMINAL 
AORTIC ANEURYSM AND THE EFFECT OF INTRALUMINAL THROMBUS, 
SMOKING AND DIAMETER GROWTH RATE. 
 
Study IV was directed at systematically mapping the pathophysiology of AAA, with 
consideration of growth rate and smoking, to identify the most relevant mechanisms. As the 
rate of OAR is decreasing in favor of EVAR, the study of processes active in AAA tissue has 
been made less available. Our research group has previously assembled large biobanks to 
study vascular disease and the present study made use of StAAAB, detailed in section 3.2. 
With this resource, the largest transcriptomic analysis of AAA tissue to date was performed. 
In addition to the presented analyses, the microarray data will be made publicly available and 
may subsequently be used by the international research community to understand AAA 
pathophysiology, identify biomarkers and to find human data for drug target development.  
 
Patient characteristics 
 
Patients, median age 69 (IQR 65-75), were significantly older than controls, median age 53 
(IQR 44-68), and there was a trend towards a smaller proportion of women among the 
patients with AAA. All comparisons between AAA and control were therefore adjusted for 
age and sex. Diameters of included AAA were median 60 (IQR 56-70) mm which meant that 
included AAA were late-stage and any early transient events in AAA development could thus 
not be detected. Further, ruptured AAAs were not included due to the inherent obstacles of 
obtaining informed consent preoperatively.  
 
Bioinformatic overview 
 
All tissues were divided into media and adventitia. The transcriptomes of AAA and control 
aortas, as well as between tunica media and adventitia, were generally distinct with a large 
number of differentially expressed genes (Figure 20A) and a tendency to cluster together in 
unsupervised t-SNE analysis of the genes with highest variance (Figure 20B). Most genes 
were dysregulated in a specific tunica and the present data identified thousands of additional 
genes compared with previous microarray studies. Many of the genes upregulated in AAA 
media were normally predominant in the adventitia of controls while those downregulated in 
AAA media were predominant in the media of controls. Transcription factors predicted from 
upregulated genes were mainly related to hematopoietic tissue while those predicted from 
downregulated genes were related to tissue of mesenchymal origin, such as SMC-rich organs 
and adipose tissue in the case of media and adventitia, respectively. Further, it was observed 
that a group of genes related to inflammation, SMC migration, ECM organization and 
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disassembly that were dysregulated in AAA predominated in the adventitia of controls but 
instead in the media of AAAs, thus switching their anatomical pattern in AAA disease.  
 
While some biological processes were transmural in AAA, others were tunica-specific. 
Adaptive and innate immunity were highly upregulated in both media and adventitia of AAA 
(Figure 21), with the most dominant components being T- and B-cell activity, IFNγ and 
chemotactic molecules. Specific to the AAA media was the downregulation of muscle cell 
development and contraction, differentiation and adhesion gene sets along with upregulated 
ECM disassembly, angiogenesis, apoptosis and phagocytosis (Figure 21A-B). The adventitia 
specifically showed downregulation of gene sets related to metal ion response and lipid 
metabolism (Figure 21C-D). There were general agreement between Enrichr and GSEA 
analyses against GO:BP and MSigDb Hallmark gene sets.  
 
 
 
 
 
Figure 20. Dysregulated genes and unsupervised clustering. A: Dysregulated genes between AAA and 
control tissue, divided into media and adventitia. B: Unsupervised clustering by t-distributed stochastic 
neighbor embedding based on the 100 genes of the highest variance across all samples.  
Abbreviations; AAA: abdominal aortic aneurysm, Ctrl: control.  
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Differentially expressed genes in media and adventitia 
 
Many of the most upregulated genes had not been described in AAA disease. MXRA5 is 
mainly expressed in fibroblasts and features anti-fibrotic and anti-inflammatory properties 
(384). LUM is a pro-inflammatory small proteoglycan regulating fibrillogenesis (385). FRZB 
is a Wnt antagonist that was highly downregulated in AAA media but instead upregulated in 
adventitia. The Wnt/ β-catenin pathway affects expression of several molecules relevant to 
AAA disease, including MMPs (386). Several of the most upregulated genes had previously 
been investigated with regard to aortic aneurysm disease, including MMP12 (128), CXCL8 
(387), CXCR4 (388) and RGS1 (389). Macrophage-specific deletion of NTN1 inhibits 
experimental mice aneurysms (390), it was however highly downregulated in the AAA media 
of the current data. VCAM1 is important in angiogenesis and increased in the circulation of 
patients with AAA (136).  
 
The most downregulated genes not previously associated with AAA include PRG4, NPR1 
and ADRA2C. PRG4 is a structural ECM protein with important biomechanical roles in 
cartilage but can also act as an anti-inflammatory buffer and is involved in the resolution of 
inflammation (391). It is dysregulated in chronic inflammation and upregulated in calcified 
carotid plaques (391,392). NPR1 is normally most abundant in the aorta (351) and was 
strongly downregulated together with NPR2, -3 and ligand NPPB/BNP in AAA. The 
resulting proteins play key roles in cardiovascular homeostasis (393). Transmurally 
downregulated ADRA2C is also normally predominantly expressed in the aorta and is 
important for neurotransmitter control (351,394). 
 
Known and emerging pathophysiological processes 
 
Several ECM-related processes described in sections 1.2.1 and 1.2.3 were dysregulated in 
AAA, preferentially in tunica media. These included upregulated proteolysis, ECM 
disassembly and peptidase activity whereas ECM and elastic fiber assembly, adhesion and 
glycosaminoglycan production were downregulated. Specifically, MMP1, -2, -7, -9, -12 and 
-13, CTSB, -C, -G, -H, -K, -L, -O, -S, -W, -Z, CMA1, ADAM8, -10, -12, -17 and -28 as well 
as ADAMTS12 and 14 were upregulated in AAA media whereas TIMP3 and -4 were 
downregulated. In media, MMP12, -1, and -9 were the 1st, 63rd and 79th most upregulated 
genes. In addition to upregulation of disruptive enzymes, important constituents of the normal 
aortic wall were downregulated. These include genes coding for components of the elastic 
lamina such as elastin, fibulin 5 and emilin 1, collagens including IV, VI, VIII, XIV and 
XVIII, proteoglycans aggrecan, biglycan, syndecan 4, osteoglycin, PRELP, asporin, 
osteomodulin, chrondroitin sulfate proteoglycan 4, fibromodulin, heparan sulfate 
proteoglycan 2, SPOCK1, glypican -1 and -4 as well as several integrins. Proteoglycans 
previously linked to aneurysm disease include potentially protective syndecan (123), 
biglycan (124), mast cell secretory granule-associated serglycin, collagen XV, which has 
been associated with severity of thoracic aortic aneurysm (125), and collagen XVIII which 
is a circulating marker of AAA diameter (126). As important functions in normal arteries 
have been described, and new interactions with for example inflammation are being 
elucidated, the role of proteoglycans in AAA requires further attention. Several laminin-
coding genes were downregulated, LAMA2 and -5 transmurally, LAMB2, LAMC1- and -2 
specifically in media and LAMA3, LAMB1 in adventitia whereas LAMA4 was upregulated 
in media. Laminin is an integral basement membrane protein, affecting many functions such 
as cellular survival, migration and differentiation, and elastase-derived fragments of laminin 
can stimulate macrophages to release plasminogen activator, urokinase, receptor (PLAUR) 
and MMP9, both upregulated in AAA media (395). Plasmin can in turn activate MMPs and 
degrade pericellular proteins, causing detachment and inducing death of mesenchymal cells 
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(98). In the present study, it was observed that both PLAU and PLAUR were upregulated in 
AAA media whereas potent plasmin inhibitor serine protease inhibitor (SERPIN)-F2 was 
among the most downregulated transmurally. In summary, the transcriptome of the AAA 
media displays a strong pro-proteolytic profile. 
 
The AAA media further showed strong downregulation of muscle cell development and 
contraction, as well as increased apoptosis, in line with AAA pathophysiology described in 
section 1.2.4. Phenotypic modulation of vSMCs in AAA is an emerging field of research 
(145,147,148) and the present material paints a compatible picture, with downregulation of 
TGF-β-, differentiation-, adhesion- and contraction-related gene sets in AAA. Transcription 
factor KLF4 has been described as central for vSMC differentiation of atherosclerosis (146) 
and was upregulated in AAA media.  
 
The well-known chronic inflammation of AAA was apparent in both media and adventitia 
and was aggravated by smoking. One of the most consistent signals in the bioinformatic 
analyses was that of IFNγ and T- and B-cells, which were upregulated in AAA compared 
with controls and increased further in the presence of ILT, cigarette smoke exposure and 
rapid diameter growth rate. These processes also tended to switch tunica predominance from 
adventitia in controls to media in AAAs. As elaborated on in section 1.2.5, the role of IFNγ 
in animal models of aneurysm is ambiguous. The strong upregulation of IFNγ-related gene 
sets in AAA with further augmentation during active smoking and fast diameter growth rate, 
along with increased AAA expression of IFNG and related genes CXCL10, IFNGR1 and -2, 
IRF1, and -8 suggests an important role and motivates further study of this pathway. Adaptive 
immunity by B- and T-cells has long been a suspected culprit in AAA disease, with signs of 
autoimmunity present in the AAA wall (149). There are however reports of deleterious 
effects of strong immunosuppressive treatment (162,163), why more specific drugs could 
potentially be tried in the future. Other enriched gene sets included those of mast cells, NK 
cells, neutrophils, phagocytosis and pathways such as NF-κB, with upregulation of NFKB1 
and TNF, and NLRP3 inflammasome, with upregulated NLRP3, IL1B and IL18.  
 
There was upregulation of angiogenesis and HIF1A in the AAA media, suggesting a hypoxic 
milieu. Oxidative stress, hypoxia and angiogenesis may aggravate many processes central to 
AAA pathophysiology, as described in section 1.2.6. Genes coding for the major antioxidants 
metallothioneins (MTs) were consistently downregulated in adventitia, with several MT1-
related genes also downregulated in media. Other downregulated genes were those coding 
for antioxidants superoxide dismutase 3 and glutathione peroxidase 3. The roles of these 
molecules are a relevant subject to study further.  
 
Several signaling pathways described in section 1.2.7 were dysregulated in AAA. The TGF-
β-axis, including genes TGFB1I1, TGFB3 and SMAD3,-4, -6, -9 were downregulated in 
media, as was the Notch axis, including genes NOTCH1, -2 and -3. MAPK8 and -9 were 
upregulated in adventitia but not in media.  
 
Transcription factor prediction and comparison with previous GWAS findings.  
 
Many of the transcription factors predicted from differentially expressed genes were 
themselves among the most differentially expressed transcription factors. Transcription 
factors from upregulated genes were generally of hematopoietic origin and related to immune 
functions, whereas those from downregulated genes were mesenchymal and related to SMC, 
ECM and adhesion, which correlates with findings in previous reports (396).  
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Examples of upregulated transcription factors predicted from upregulated genes were 
ZNF267, a KLF family member of largely unknown function that is upregulated in non-
alcoholic fatty liver disease and cirrhosis (397). IRF4 is important for differentiation of 
immune cells as well as to promote SMC dedifferentiation and to protect against neointima 
formation in a KLF4-dependent manner (398). IRF8 can be expressed in cardiomyocytes and 
lymphocytes, promotes macrophage differentiation, is essential for B-cell development and 
increases vascular hyperplasia (399). STAT4 is of importance for a wide variety of immune 
cells and is increased in tissue from failing hearts (400). IKZF1/-3 plays major roles in 
lymphocyte differentiation (401).  
 
Downregulated transcription factors predicted from downregulated genes included TEAD3, 
among family members required for YAP-binding to DNA and mainly expressed in SMC-
rich tissue (351,402). Deficiency of YAP leads to cellular senescence and YAP1 was 
downregulated in AAA media of the current data. OSR1 was transmurally downregulated in 
AAA but has a higher expression in normal aorta than in other tissues (351). It has been 
shown to be regulated by IKZF1 and RUNX2 – both of which were transmurally upregulated 
in AAA (403). ATOH8 is important in skeletal embryogenesis, among others, and can 
participate in muscle fiber regeneration (404). TWIST2 is expressed in progenitor cells that 
contribute to myocardial regeneration (405). 
 
Several genes located close to risk loci identified in a recent meta-analysis (211) were 
dysregulated in the AAA media. Specifically, MMP9, LDLR and long non-coding 
CDKN2B-AS1/ANRIL were upregulated whereas DAB2IP, ERG, LDLR, PC1F1, SORT1 
were downregulated in AAA media. LINC00540 was significantly upregulated in AAA but 
filtered due to low expression levels. It is important to note that mere proximity between a 
SNP and a gene is not sufficient evidence of a functional connection.  
 
Tunica switching 
 
A number of genes upregulated in AAA media, that in AAAs showed higher expression in 
media than adventitia, were in controls to the opposite expressed to a higher extent in 
adventitia compared with media, thus switching tunica predominance. These included genes 
coding for molecules previously implicated as culprits in AAA disease such as MMP1, 2 and 
9 (406,407), CTSL and –H (408), PLAU (98), LYZ (409), DPP4 (410) and CHI3L1 (235) as 
well as the enrichment of gene sets related to proteolysis and inflammation, including T- and 
B-cells and IFNγ. Others were VCAM1, potentially indicating the increased density of 
neovessels in ILT-covered AAA media, TREM1 which is an amplifier of innate immune 
response shown to mediate inflammatory remodeling after myocardial infarction (411), 
HLA-related genes, IFNγ-inducible lysosomal thiol reductase (IFI30) and AIF1 which is 
mainly expressed in macrophages and T-cells, promotes inflammation and induce increased 
VSMC migration and MMP2- and -9 production in response to oxidized low density 
lipoprotein (412). Considering the high enrichment of genes and processes described as 
pathological and central to AAA disease among those that switch wall layer predominance 
from adventitia to media, such genes, proteins and processes not previously investigated in 
AAA could be important targets for future intervention and investigation.  
 
Effect of ILT 
 
It was observed that an ILT had a transcriptomic effect on the underlying media, but not 
adventitia. Genes exclusively upregulated in the ILT-covered media of AAA compared with 
control media were related to transcription, angiotensin maturation, proteolysis and ECM-
organization. The ILT-covered compared with ILT-free media displayed higher expression 
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of genes related to of Hallmark immune gene sets and GO BPs related to gene expression, 
translation and transcription, ECM organization, angiogenesis and B-/T-cell activation and 
GO MFs such as vascular endothelial growth factor binding. There was a lower expression 
of genes included in GO BPs related to metabolism, neutrophil activation, protein folding, 
cell-matrix adhesion and cellular response to TGF-β. Genes upregulated in AAA media that 
were increased in ILT-covered compared with ILT-free wall included MS4A1, coding for B-
cell surface molecule CD20, SFRP4, a Wnt inhibitor which can but does not always initiate 
apoptosis (413), immunoglobulin-associated JCHAIN and IGKC as well as CCL19 and 
CCL20 which are chemotactic for B- and T- cells and activated T-cells, respectively, and 
IRF4, described above. Examples of genes downregulated in AAA media that were further 
downregulated in ILT-covered compared with ILT-free media were SORT1, implicated in 
GWAS of AAA (211), KCNMA1, related to regulation of vSMC contraction as well as 
adhesion-related ITGB3, CDH13 and PCDH10.  
 
Active smoking and diameter growth rate 
 
To prioritize above mechanisms, associations between gene expression, smoking and 
diameter growth rate were investigated. All tissues showed increased signs of oxidative stress 
in response to active smoking. Further, the transcriptomic effect of smoking on control aortas 
aligned to a large extent with what is known about AAA disease processes, with increased 
inflammation-, angiogenesis-, apoptosis- and peptidase-related gene sets, along with a 
decreased expression of those related to muscle cells in tunica media. This presents an 
explanation of how tobacco smoke could injure the normal vessel wall. Further, AAAs 
exposed to smoking showed increased inflammation and apoptosis, with increased SMC de-
differentiation and proliferation in media and increased lipid-related processes in adventitia. 
The diameter growth rate correlated with gene sets related to B- and T-cells, adaptive immune 
response and IFNγ in the AAA media as well as fatty acid/lipid-related gene sets in adventitia.  
 
Comparison with previous studies, technical considerations and limitations 
 
Several previous microarray studies have been published, some of which have compared 
AAA tissue to that of control aortas, as shown in Table 2. These studies have been performed 
on full-thickness samples without consideration of the ILT. The present study analyzed media 
and adventitia separately from ILT-covered and -free aspects of the AAA vessel wall. This 
approach appears to be important considering that the tunicas were distinct in unsupervised 
and supervised clustering and that many of the dysregulated genes and several of the enriched 
processes were specific to one tunica. Further, the present study detected a large number of 
disease-associated genes that were not detected in the two previous similar studies, while 
very few genes dysregulated in both previous studies were not also detected in the present 
study. The transcriptomic changes related to smoking and fast diameter growth rate have not 
been analyzed previously.  
 
Some technical considerations deserve mentioning. Due to the limited access to non-
aneurysmatic abdominal aorta from subjects of similar ages as patients with AAA, the group 
sizes were unequal. However, the employed statistical method (limma) does not make 
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enrichment. Despite this adjustment, a large number of genes were significantly dysregulated 
between AAA and control tissue, especially in media.  
 
The biobank has been assembled over a long period of time and, therefore, analyses were 
made to detect batch effects, if any. In these analyses, a strong consistency of dysregulated 
genes between samples collected in early and recent years was found. Principal component 
analysis further suggested that AAA vs control, patient age, tunica and ILT-coverage were 
the most influential variables for between-sample variation in gene expression (not shown). 
The macroscopic dissection of wall layers into media and adventitia has been used previously 
by our and others groups and is technically uncomplicated (416–418) but an exact border 
between media and adventitia is difficult to find in AAA due to transmural fibrosis and vSMC 
death. Markers of vSMC and adipose tissue (223) were studied and found to predominate in 
the media and adventitia (not shown), respectively, as would be expected from a working 
dissection protocol. 
 
The use of transcriptomics technologies has increased explosively due to the powerful results 
produced with increasing speed and affordability, see section 1.2.11. Some limitations to the 
technique in general, as well as its use specifically in this project, merit consideration. The 
gene expression as measured by microarrays is relative to that of other included samples and 
the expression levels are in a non-linear manner based on the relative concentration of RNA 
rather than absolute amounts. As such, a highly increased expression of one set of genes will 
make the other sets of genes appear downregulated despite retaining the same absolute 
expression level. The gene expression can be investigated on a cellular or bulk level. This 
project is based on analyses of bulk RNA expression, meaning RNA copies from many 
different cells are measured at the same time. With this approach it is not possible to discern 
whether a differential expression is the result of changed transcriptional regulation in the 
same cells, influx of new cells or absence of previously existing cells. Presumably, the above 
described perturbations are a combination of all these events. The current project also did not 
consider differential splicing or non-coding RNA, both highly important for the effect of 
expressed RNA. It also has to be considered that the underlying assumption from pathway 
analyses that expressed mRNA correlates with active proteins is simplistic and does not 
consider important post-translational modification, degradation or activation.  
 
Summary 
 
The described approach allowed the identification and localization of known and emerging 
disease processes such as ECM degradation, loss and dedifferentiation of vSMCs, 
inflammation, angiogenesis and oxidative stress, as well as the detection of thousands of 
genes novel to the understanding of AAA. For the first time, the transcriptomic effects of an 
overlying ILT, active smoking and rapid diameter growth rate were described. A process was 
described where sets of genes related to inflammation and proteolysis predominant in the 
adventitia of controls were overrepresented instead in the media of AAAs. This data will be 
made publicly available and can aid future research efforts.   
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5 CONCLUSIONS AND FUTURE DIRECTIONS 
 
5.1 CONCLUSIONS 
 
This thesis was designed to explore and develop new strategies to improve, refine and 
individualize management of patients with AAA by applying geometric, biomechanical and 
molecular analyses. From the included projects we made the following conclusions:  
 
§ Clinical risk factors of AAA rupture are associated with FEA-derived biomechanical 
stress and rupture risk indices. This gives biomechanical insights into clinical 
observations and further motivates the use of 3D modeling and FEA to predict 
outcomes of AAA. 
 
§ 3D modeling improves the ability of diameter measurements to predict growth and 
future indication for surgery of AAA. Additional biomechanical variables in 
multivariable models tuned in machine learning did not improve predictions. On the 
other hand, lumen diameter and biomechanical rupture risk indices were able to predict 
future rupture or symptomatic AAA. Growth and rupture require different prediction 
models and additional variables or markers as well as pathophysiological insight, are 
needed. 
 
§ E-XDP is a marker of AAA and ILT presence and size, as well as the mechanical stress 
of the ILT itself, and could possibly be used to monitor the development of an ILT or 
the extent to which it is in contact with flowing blood. 
 
§ Main pathophysiological features, as inferred from gene expression patterns, include 
inflammation transmurally and increased proteolysis, angiogenesis, apoptosis as well 
as decreased muscle contraction, development, differentiation and adhesion in the 
media. The adventitia displayed downregulation of metal ion response and lipid-
related processes. Smoking caused AAA-like transcriptomic changes in control aortas. 
Growth rate was associated with adaptive immunity in media and lipid-related 
processes in adventitia. A large number of genes not previously described in AAA 
disease were detected.  
 
In summary, these projects have found biomechanical explanations for clinical risk factors, 
made improvements in predictions of AAA outcome and growth by geometric and 
biomechanical modeling, discovered a new biomarker of AAA and mapped AAA 
pathogenesis including the molecular fingerprint of smoke exposure and diameter growth. 
Together, these findings suggest that the care of patients with AAA can be improved and 
personalized by use of geometric, biomechanical and molecular analyses. 
5.2 FUTURE DIRECTIONS 
 
A number of potential directions towards improved management of patients with AAA can 
be sketched out from these results along with the progress of the field. Future projects should 
develop and prospectively validate FEA, create more sophisticated machine learning models 
for AAA outcome prediction and use imaging and biobank resources for high-throughput 
multi-systems analysis and prediction modeling.  
 
The FEA methodology as applied to AAA has improved in the last twenty years. However, 
several potential improvements remain. These may include taking signs of a fractured ILT 
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into account and improving the wall strength model by biaxial testing, more detailed patient 
descriptions and to factor in vessel wall calcifications. Probabilistic approaches to rupture 
risk estimation require extensive computation and time but lead to improved predictions 
(330,331). Histomechanical constitutive descriptions of AAA is a complex but promising 
prospect under investigation (419). The FEA methodology used in this thesis can predict 
AAA rupture by retrospective analysis of pre-rupture images (270,330) but it has not been 
prospectively validated. Our research group is currently performing a prospective study on 
patients with small AAAs in which patient records are collected in a standardized manner, 
CTA imaging is systematically performed two times with a two-year interval and a clinical 
follow-up is completed after five years. 
 
A machine learning framework could be applied to any range of geometric, biomechanical 
or molecular features to predict outcome of AAA. An ideal future study should include a 
large number, possibly a thousand or more, patients who undergo at least two CTAs at regular 
intervals and have their blood sampled at both instances. 3D models of the AAA, spatial 
maps of biomechanical load as well as data derived from radiomics (defined as the high-
throughput analysis of quantitative imaging features) (420) could then be collected from 
imaging while genomics and plasma proteomics, metabolomics and transcriptomics could be 
mined from blood samples. These features would then be highly compatible with any 
machine learning approach to predict growth and rupture of AAA.  If made publicly 
available, this data could be used by international research groups to find the most effective 
and robust prediction algorithms. In our ongoing prospective study described above, there 
are also plans to include blood samples in the protocol. This will result in a multi-level dataset 
on AAA progression aimed to be used with above considerations. Although around 100 
patients are treated surgically for AAA at the Karolinska University Hospital every year, the 
challenge of amassing and analyzing a large-scale dataset comprising thousands of patients 
described by detailed imaging and biological data is well-suited for international 
collaborations.  
 
With study IV, a first step in a systems-biology effort to comprehensively map the AAA 
pathophysiology was made. The most differentially expressed genes and resulting proteins 
need to undergo mechanistic studies to determine their respective roles. While microarrays 
yield powerful results, large domains of biological information remain to be explored. Future 
steps could include epigenomic, genomic, proteomic and single-cell analyses. Integrating 
these levels of information could uncover eQTLs, clinically relevant heterogeneities within 
and between patients (421) and, when combined with biomechanical data on the AAAs, open 
paths toward precision medicine and provide foundational support for future drug target  
identification. Fortunately, the StAAAB was developed at the outset with these kinds of 
applications in mind, allowing continued progress in this area.  
 
This thesis implemented 3D analysis, FEA, prediction modeling aided by machine learning 
and multi-level bioinformatic analyses. Performance and robustness of findings could 
increase and avenues for improvement of current guidelines may open with the entry of high-
throughput technology (“-omics”), rapid biomechanical evaluation, detailed 
pathophysiological data and machine learning principles into the field of aneurysm research. 
With the included papers, a foundation for this type of approach has been established.   
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